BLOOD MANAGEMENT IN DISASTER SITUATIONS IN PAKISTAN
CHALLENGES IN SETTING UP AN ACCREDITATION SYSTEM IN AFRICA - WHAT CAN BE LEARNT
THE STEPS TAKEN FOR ESTABLISHING A BLOOD SERVICE IN CHILE
BLOOD COLLECTION AND PROCESSING: QUALITY GUIDELINES AND STANDARDS REFLECTING COMMON BEST PRACTICE STANDARDS REFERRING TO THE EUBIS MANUAL AND GUIDE
QUALITY INDICATORS: A TOOL FOR QUALITY MONITORING AND IMPROVEMENT
MANAGEMENT OF PATIENTS WITH ACUTE BLEEDING WHO REFUSE BLOOD TRANSFUSION
GI HAEMORRHAGE
UPDATE ON TRAUMA
GENETIC CLASSIFICATION OF BLOOD GROUPS
PROTEIN BLOOD GROUP SYSTEMS: BERLIN AND BEYOND
THROMBOTIC THROMBOCYTOPENIC PURPURA: MANAGEMENT ISSUES
ANTICOAGULANTS AND THEIR REVERSAL: THE ROLE OF TRANSFUSION
MANAGEMENT OF ACQUIRED COAGULOPATHIES IN ITU
WHAT IS A CLINICALLY SIGNIFICANT ANTIBODY?
WHAT METHODS AND PROCESS FLOW CAN ASSIST IN ALLOANTIBODY IDENTIFICATION
WHERE DO WE GET BLOOD FOR DIFFICULT CASES?
PLASMA FRACTIONATION
PREGNANCY IMMUNOLOGY AND MATERNAL ALLOIMMUNE RESPONSES
HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN: FROM BENCH TO BEDSIDE
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: FROM BENCH TO BEDSIDE
A BLOOD-BASED ASSAY FOR DETECTION OF PRION INFECTION: CAN IT BE USED TO SCREEN BLOOD DONATIONS?
OPTIMIZATION, EVALUATION AND VALIDATION OF A PROTEIN MISFOLDING CYCLIC AMPLIFICATION (PMCA) BASED CONFIRMATORY SCREENING ASSAY TO DETECT PRIONS IN HUMAN BLOOD
TTID RISKS IN THE CARIBBEAN AND LATIN AMERICA:RECOMMENDATIONS TO IMPROVE SAFETY
THE ISBT WORKING PARTY FOR TRANSFUSION-TRANSMITTED INFECTIOUS DISEASE (WP-TTID) SURVEY FOR NAT TESTING IN LATIN AMERICA
ECMO - THE CLINICIAN's VIEW
PREDICTORS OF INCREASED TRANSFUSION REQUIREMENTS AND OPTIMIZING TRANSFUSION SUPPORT IN PATIENTS ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
EXTRACORPOREAL LESSONS FROM SHEEP
PUBLIC VS PRIVATE FUNDING FOR BLOOD SERVICES: WHICH IS BETTER FOR PATIENTS?
ORGANIZING BLOOD ESTABLISHMENT IN LAOS
THE NATIONAL ORGANISATION IN A SHRINKING ECONOMY
PRODUCTION AND CHARACTERIZATION OF CULTURED RED CELLS
PROGENY GENERATION FROM PLATELETS: WHAT WE KNOW AND WHERE WE NEED TO GO?
MODELING TRANSFUSION REACTIONS WITH KODECYTES AND ENABLING ABO-INCOMPATIBLE TRANSFUSION WITH FUNCTION-SPACER-LIPID CONSTRUCTS
HEMOLYSIS OF COMPATIBLE OLDER, STORED RED CELLS FOLLOWING TRANSFUSION
DEL BLOOD DONORS ALLOIMMUNISED PATIENTS: THE CANADIAN EXPERIENCE
RHD PCR OF BLOOD DONORS IN NORTHERN GERMANY: USE OF ADSORPTION/ELUTION TO DETERMINE D ANTIGEN STATUS
APHERESIS VS WHOLE-BLOOD-DERIVED PLATELETS: PROS AND CONS
GENERATION OF POLYMORPHONUCLEAR NEUTROPHILS PRIMING ACTIVITY BY PLATELET-DERIVED MICROPARTICLES IN STORED APERESIS PLATELET CONCENTRATES
A NEW DEHYDRATION METHOD TO STORE BLOOD PLATELETS: ZEODRATION
ROOM TEMPERATURE EXPOSURE ON RED BLOOD CELLS: EFFECTS ON BACTERIAL GROWTH
IRRADIATED RED CELL CONCENTRATES: ACCELERATED STORAGE LESION AND ALTERATIONS IN MEMBRANE PROTEIN COMPOSITION
HEMOVIGILANCE IN HONDURAS, THE BLOOD CENTER PERSPECTIVE
DEVELOPING HAEMOVIGILANCE IN LATIN AMERICAN COUNTRIES
RISK OF MAJOR ALLERGIC REACTIONS IN RECIPIENTS OF BLOOD FROM ALLERGIC DONORS
NATIONAL DATABASE OF IRREGULAR ANTIBODIES NOW FUNCTIONAL: ESTIMATION OF AVOIDABLE ADVERSE REACTION AND INCIDENT REPORTS TO HEMOVIGILANCE REGISTRY
ESTIMATED TRANSFUSIONAL RISK OF HIV IN COLOMBIA, FROM 2007 - 2010
PREVALENCE AND INCIDENCE OF HIV INFECTION AT FIVE CHINESE BLOOD CENTERS, 2008–2010
A MATHEMATICAL APPROACH TO DETERMINE EFFICACY OF NAT IN REMOVING TRANSMISSION RISK OF OCCULT HBV INFECTION BY BLOOD COMPONENTS
RESULTS OF THE IMPLEMENTATION OF A COMPUTER-BASED SELF-INTERVIEW SYSTEM (CBSIS) FOR BLOOD DONORS
MOLECULAR HPA GENOTYPING BY MICROARRAY IN BRAZILIAN BLOOD DONORS
NEW INSIGHTS INTO TRALI: ACTIVATION OF MONOCYTES AND ENDOTHELIAL CELLS AS TRIGGERS OF TRANSFUSIONRELATED ACUTE LUNG INJURY
THE RESIDUAL RISK OF TRALI IN A LARGE U.S. BLOOD SYSTEM REFLECTS THE ONGOING RELIANCE ON AB PLASMA FROM FEMALE DONORS TO MEET DEMAND
CHARACTERIZATION OF IGA DEFICIENCY, IDENTIFIED AMONG PATIENTS WHO HAD EXPERIENCED NONHEMOLYTIC TRANSFUSION REACTIONS AND AMONG HEALTHY BLOOD DONORS
EFFECTS OF STORED RED BLOOD CELL TRANSFUSION IN CARDIOPULMONARY FUNCTION AND INFLAMMATION: AN EXPERIMENTAL MECHANISTIC STUDY
RED BLOOD CELL ALLOIMMUNIZATION AND ANTIGEN MATCHING IN SICKLE CELL DISEASE - THE AFRICAN PERSPECTIVE
RELEVANCE OF RH VARIANTS IN TRANSFUSION OF SICKLE CELL DISEASE PATIENTS
TRANSFUSION CHALLENGES IN PATIENTS WITH THE RARE S-S- (MNS:-3,-4) BLOOD TYPE: A 15-YEAR EXPERIENCE
IDENTIFICATION OF GENETIC POLYMORPHISMS ASSOCIATED WITH RESPONSE TO RHD IMMUNISATION FOR THE DEVELOPMENT OF A GENOTYPING ASSAY TO PREDICT RESPONSE STATUS
WHAT IS THE APPROPRIATE SIZE OF THE WORLDWIDE CORD BLOOD INVENTORY?
TRANSPLANTATION OF UNRELATED PLACENTAL BLOOD STEM CELLS IN MEXICO
CORRELATION OF HLA-G EXPRESSION WITH GRAFT-VERSUSHOST REACTION FOLLOWING HSCT
EXPANSION OF MESENCHYMAL STEM CELLS FROM CORD BLOOD FOR CLINICAL APPLICATION
EX VIVO DIFFERENTIATION OF PLACENTAL MESENCHYMAL STEM CELLS TOWARDS HEPATIC AND PULMONARY EPITHELIAL COMPARTMENTS
NEW CONCEPTS IN NON-INVASIVE PRENATAL DIAGNOSIS USING CELL-FREE DNA IN MATERNAL PLASMA: FROM THE GENE TO THE CHROMOSOME TO THE GENOME
SUGAR-FREE ANTIBODIES: A NEW TREATMENT MODEL FOR ITP AND AIHA
PHASE-II RANDOMIZED, DOSE-FINDING STUDY OF ROLED-UMAB, A NOVEL MONOCLONAL ANTI-RHD IGG1, COMPARED TO POLYCLONAL ANTI-RHD IGG IN CLEARING RHD POSITIVE RED BLOOD CELLS IN RHD-NEGATIVE HEALTHY VOLUNTEERS
RELATIONSHIP OF WARM AUTOIMMUNE HAEMOLYTIC ANEMIA TO NORMAL RED BLOOD CELL SENESCENCE
THE CONUNDRUM WHEN USING DIFFERENT MOUSE BACKGROUNDS TO ESTABLISH THE ROLE OF THE INHIBITORY FC RECEPTOR IN THE MECHANISM OF IVIG IN AUTOIMMUNE DISEASES
SPECIFIC DAT - 10 YEARS EXPERIENCE WITH DC SCREENING I ID-GELCARD
TRANSFUSION-TRANSMITTED MALARIA IN COUNTRIES WHERE MALARIA IS ENDEMIC
BASIGIN IS AN ESSENTIAL RECEPTOR FOR ERYTHROCYTE INVASION BY PLASMODIUM FALCIPARUM
VALIDATION OF MODELS FOR MALARIA RISK IN UNITED STATES BLOOD DONORS DEFERRED FOR TRAVEL TO MEXICO BY ANTIBODY TESTING
DEVELOPMENT AND IMPLEMENTATION OF A PEDIATRIC MASSIVE TRANSFUSION PROTOCOL
SUMMARY OF THE CONSENSUS REPORT ON MASSIVE BLEEDING
IMPACT OF MASSIVE TRANSFUSION DEFINITIONS ON CRITICAL BLEEDING EVENT CAPTURE AND OUTCOMES
PREOPERATIVE HEMOSTASIS AND ITS ASSOCIATION WITH PERIOPERATIVE BLEEDING AND BLOOD COMPONENT TRANSFUSION REQUIREMENTS IN CARDIOPULMONARY BYPASS SURGERY
UTILIZATION OF THERAPEUTIC APHERESIS IN THE UNITED STATES
MONITORING THE EFFECTIVENESS OF PLASMA-EXCHANGE IN ACUTE IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) WITH A REAL-TIME ASSAY FOR DOSAGE OF ADAMTS-13 ANTIGEN, ACTIVITY AND INHIBITOR
RED BLOOD CELL SUPPLY MANAGEMENT: TOOLS FOR ASSESSMENT AND IMPROVEMENT
CLINICAL EXPANSION OF CYTOLKINE INDUCED KILLER (CIK) CELLS
NATURAL KILLER CELL THERAPY IN CANCER AND TRANSPLANTATION
EFFECTIVE THERAPY BY TRANSFUSING ALLOGENEIC TOLEROGENIC DENDRITIC CELLS IN THE MODEL OF AUTOIMMUNE ARTHRITIS
INFLUENCE OF CELL CONCENTRATION ON THE EXPANSION OF MESENCHYMAL STROMAL CELLS DERIVED FROM BONE MARROW OR ADIPOSE TISSUE AND CULTURED IN MEDIUM ADDITIONED WITH PATHOGEN-FREE PLATELET LYSATE
NONINVASIVE PRENATAL SCREENING FOR RHD: THE 1ST NATIONAL ANTENATAL DIRECTED RH PROPHYLAXIS PROGRAMME - THE DANISH MODEL
NONINVASIVE PRENATAL SCREENING FOR RHD IN THE NETHERLANDS: ONE TEST FOR TARGETED ANTENATAL AND POSTNATAL ANTI-D PROPHYLAXIS
NONINVASIVE PRENATAL SCREENING FOR RHD: THE STOCKHOLM STUDY
IMPLEMENTATION OF ROUTINE OF FETAL RHD TYPING IN ALL RHD-NEGATIVE PREGNANT WOMEN: TIMING, COSTS, AND EFFICIENCY
RHD ALLELES IN ISOIMMUNIZED AND NON-ISOIMMUNIZED RHD NEGATIVE PREGNANT WOMEN
EARLY TREATMENT WITH TRANEXAMIC ACID SAFELY REDUCES MORTALITY IN BLEEDING TRAUMA PATIENTS AND ITS USE SHOULD NOT BE RESTRICTED TO THE MOST SEVERELY INJURED
FIBRINOGEN CONCENTRATES IN BLEEDING TRAUMA PATIENTS
HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACUTE ANEMIA AFTER PRIMARY POSTPARTUM HEMORRHAGE: A RANDOMIZED CONTROLLED TRIAL OF RED BLOOD CELL TRANSFUSION VS EXPECTANT MANAGEMENT:THE WOMB STUDY
THE FREQUENCY OF CENTRAL NERVOUS SYSTEM (CNS) BLEEDING IN PLATELET TRANSFUSION DEPENDENT PATIENTS BEFORE AND AFTER INTRODUCTION OF PATHOGEN INACTIVATED COMPONENTS: A 9 YEAR HEMOVIGILANCE SURVEY
INTRODUCTION OF A PROGRAM FOR VOLUNTARY BLOOD DONATIONS IN IRAN (BLOOD TRANSFUSION STATUS IN IRAN)
INTRODUCTION OF PROGRAMS FOR VOLUNTARY BLOOD DONATION IN CENTRAL AMERICA
CHANGING FROM PERMANENT TO TEMPORARY DEFERRAL FROM BLOOD DONATION AFTER RISK BEHAVIOR - A MODEL FOR EVALUATING RISK OF TRANSFUSION TRANSMITTED HIV, HEPATITIS B AND HEPATITIS C IN A SWEDISH SETTING
‘BRING THE FAMILY’: EVALUATION OF A DONORS RECRUIT DONORS BLOOD DONATION STRATEGY
DONOR RECRUITMENT IN UNEXPLORED AREAS
HOW TO IMPLEMENT A HOSPITAL-BASED BLOOD MANAGEMENT PROGRAM
END-TO-END ELECTRONIC TRANSFUSION MANAGEMENT IN HOSPITAL PRACTICE
ALIGNING SUPPLY WITH DEMAND
THE DEVELOPMENT AND INSTITUTION OF A COLLECTIONS MANAGEMENT SYSTEM AND ITS ROLE IN ACHIEVING ORGANISATIONAL GOALS AT THE SOUTH AFRICAN NATIONAL BLOOD SERVICE
PRESERVED FUNCTIONAL AND BIOCHEMICAL CHARACTERISTICS OF PLATELET COMPONENTS PREPARED WITH AMOTOSALEN AND UVA FOR PATHOGEN INACTIVATION
QUALITY PARAMETERS OF RED CELLS AND PLASMA MANUFACTURED BY HOLLOW-FIBRE SEPARATION
PRBC MEMBRANE FRAGILITY AS A POTENTIAL STORAGETIME-INDEPENDENT QUALITY METRIC
EFFECT OF LIPEMIC PLASMA ON THE IN VITRO QUALITY OF CELLULAR BLOOD COMPONENTS DURING STORAGE
PATHOGEN REDUCTION TECHNOLOGY: EFFECT OF PROTEINS RELEASED BY TREATED PLATELET CONCENTRATES ON ENDOTHELIAL CELLS
INACTIVATION OF HUMAN WHITE BLOOD CELLS IN PLATELET CONCENTRATES AFTER PATHOGEN REDUCTION BY UVC-LIGHT IN THE THERAFLEX UV-PLATELETS SYSTEM
MECHANISMS BEHIND ADHESIVE ERYTHROCYTES IN SICKLE CELL DISEASE
CIRCADIAN RHYTHMS OF METABOLISM IN HUMAN ERYTHROCYTES
ESTABLISHMENT OF IMMORTALIZED HUMAN ERYTHROID PROGENITOR CELL LINES ABLE TO PRODUCE ENUCLEATED RED BLOOD CELLS
CURRENT STATUS OF BACTERIAL DETECTION IN BLOOD COMPONENTS - SUCCESSES AND CHALLENGES
BACTERIAL CONTAMINATION, SCREENING AND FOLLOW UP: CLINICAL ASPECTS
BIOFILM FORMATION BY STAPHYLOCOCCUS CAPITIS STRAINS ISOLATED FROM CONTAMINATED PLATELET CONCENTRATES
AN INNOVATIVE BIOLOGICAL RECYCLING PROCESS TO PRODUCE ACTIVE ANTIMICROBIAL PEPTIDES
A PRIMER ON EVIDENCE BASED PLASMA THERAPY
REDUCED NUMBER OF ADVERSE EVENTS WITH METHYLENE-BLUE TREATED PLASMA COMPARED WITH QUARANTINE STORED PLASMA: A SINGLE CENTER's 3 YEAR EXPIRIENCE
PLASMA TRANSFUSION IN LIVER TRANSPLANTATION: A RANDOMIZED, DOUBLE BLIND, MULTICENTER CLINICAL COMPARISON OF THREE VIRALLY SECURED PLASMAS
APHERESIS FOR PEDIATRIC PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA MAY LEAD TO RESOLUTION OF ATHEROMATOUS PLAQUES; WEEKLY LDL-A IS SUPERIOR TO THE BIWEEKLY REGIMEN OR PLASMAPHERESIS
CAN WE IMPROVE SAFETY FOR YOUNG BLOOD DONORS?
ADOLESCENTS AND BLOOD DONATION: MOTIVATIONS, HURDLES AND POSSIBLE RECRUITMENT STRATEGIES
‘SAVE THE LIFE’: AVIS AND THE PROMOTION OF BLOOD DONATION ON FACEBOOK
VASOVAGAL REACTION AMONG YOUNG FIRST-TIME DONORS:PREDICTION BY BODY DIMENSION AND REDUCTION AND LESS COLLECTION
CLINICAL EFFECTS OF TRANSFUSING OLDER RED CELL CONCENTRATES: AN UPDATED OVERVIEW
TOWARDS A PROPHYLACTIC TREATMENT OF HPA-1A-RELATED FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT)
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: AN UPDATE ON PRIVATE AND RARE HUMAN PLATELET ANTIGENS
HPA GENOTYPING IN PREGNANT WOMEN: VALIDATION OF ID-HPA XMAP LUMINEX® TECHNOLOGY
TITRATION OF IGg ANTIBODIES IN PREGNANCY - A SNAPSHOT OF PERFORMANCE AND POLICY IN THE UK
ROUTINE ANTENATAL ANTI-D PROPHYLAXIS AND PATIENT COMPLIANCE
PLATELET RICH PLASMA VS BUFFY COAT METHOD - IN VITRO QUALITY ASSESSMENT OF RANDOM DONOR PLATELET CONCENTRATE BY A TERTIARY CARE HOSPITAL IN INDIA
MANAGED CONVERGENCE, A POTENTIAL COLLABORATION BETWEEN BLOOD ESTABLISHMENTS, SUPPLIERS AND REGULATORS: IMPROVING SAFETY OF APHERESIS CONNECTORS
MEXICAN PROGRAM FOR EXTERNAL QUALITY ASSURANCE IN INFECTIOUS SEROLOGY, GENERAL RESULTS OF THE FIRST YEAR OF ACTIVITIES, INSTITUTO LICON
ESTABLISHMENT OF A NATIONAL ACCREDITATION PROGRAM FOR BLOOD BANKS (BB) IN INDIA UNDER NATIONAL ACCREDITATION BOARD OF HOSPITALS AND HEALTHCARE PROVIDERS (NABH)
SURVEY OF QUALITY ASSURANCE IN HEMOTHERAPY IN THE VARIOUS MEDICAL FACILITIES
RESTORING BLOOD PRODUCTION IN HAITI AFTER THE EARTHQUAKE OF JANUARY 12TH, 2010
THE OSLO MASSACRE 2011
BLOOD SUPPLY SYSTEM IN MEXICO
DONOR VIGILANCE: PROGRESS AND CHALLENGES
IRON AND CARDIAC ISCHEMIA: A NATURAL, QUASI-RANDOM EXPERIMENT COMPARING ELIGIBLE WITH DISQUALIFIED BLOOD DONORS
FREQUENCY AND RISK FACTORS FOR DONOR REACTIONS
REDUCING THE RISK OF PRE-SYNCOPE AND SYNCOPE IN HIGH VOLUME PLASMAPHERESIS COLLECTIONS
MANAGEMENT AND IMPLEMENTATION OF CONTINUING EDUCATION IN BLOOD CENTER OF ZHEJIANG PROVINCE
A ‘WIN-WIN’ APPROACH TO SUCCESSFULLY IMPLEMENT COMPETENCY ASSESSMENT FOR ALL MEDICAL TRAINEES AT A TERTIARY LEVEL LONDON TEACHING HOSPITAL
DEVELOPING A PACIFIC TRANSFUSION LEADERSHIP NETWORK TO STRENGTHEN REGIONAL TRANSFUSION PRACTICE
THE ROLE OF TRAINING AND EDUCATION IN IMPROVING QUALITY IN BLOOD TRANSFUSION SERVICES
IDENTIFICATION OF HUMAN ATP-BINDING CASSETTE (ABC) TRANSPORTERS AS CARRIERS OF HIGH-INCIDENCE ANTIGENS IN TWO NOVEL BLOOD GROUP SYSTEMS
THE JR BLOOD GROUP SYSTEM: GENETIC AND MOLECULAR INVESTIGATIONS
A NOVEL CROMER BLOOD GROUP SYSTEM ANTIGEN, CRUE, ARISING FROM TWO HETEROZYGOUS DAF MUTATIONS IN ONE INDIVIDUAL WITH THE CORRESPONDING ANTI-CRUE
PARG: A NEW LOW PREVALENCE RH BLOOD GROUP ANTIGEN
CHAGAS DISEASE: A THREAT FOR SAFE BLOOD TRANSFUSION?
STRATEGIES FOR CHAGAS PREVENTION IN MEXICO
NO EVIDENCE OF TRYPANOSOMA CRUZI INCIDENCE IN UNITED STATES BLOOD DONORS: A 4-YEAR STUDY
TRYPANOSOMA CRUZI PARASITEMIA STATUS DETERMINED BY A SENSITIVE, QUANTITATIVE PCR ASSAY CORRELATES WITH CLINICAL MANIFESTATIONS OF CHAGAS HEART DISEASE IN A COHORT OF SEROPOSITIVE BLOOD DONORS
TRANSFUSION RISK SCORE AND BLOOD USE IN CARDIAC SURGERY PATIENTS: A CARDIOVASCULAR HOSPITAL EXPERIENCE IN BOGOTÁ, COLOMBIA
DESIGNING A STRATEGY TO IMPLEMENT A COST-EFFECTIVE BLOOD TRANSFUSION POLICY IN ELECTIVE HIP AND KNEE ARTHROPLASTIES: A STUDY PROTOCOL
EVIDENCE-BASED PATIENT BLOOD MANAGEMENT GUIDELINES FOR MEDICAL PATIENTS
RBC TRANSFUSION PRACTICE IN GENERAL SURGERY, EXPERIENCE FROM A SINGLE PORTUGUESE CENTRE
ACCEPTANCE ANALYSIS AND PILOT TESTING OF A NEW ELECTRONIC BLOOD DONOR ID-CARD AT GERMAN RED CROSS BLOOD DONATION SERVICES
PLATELETS AND THE IMMUNE CONTINUUM
AUTOLOGOUS PLATELET DERIVED GROWTH FACTORS AS A TREATMENT MODALITY IN EARLY OSTEOARTHRITIS KNEE - A PROSPECTIVE RANDOMIZED CONTROL TRIAL
APPLICATION OF PLATELET-RICH PLASMA (PRP) IN DIABETIC FOOT WOUND HEALING IN A PUBLIC HOSPITAL OF BUENOS AIRES ARGENTINA
PLATELET PARTICIPATION TO INFLAMMATION IN HIV-1 INFECTED PATIENTS IS AFFECTED BY HAART
USE OF VINCRISTINE LADEN PLATELETS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES REFRACTORY TO PLATELET TRANSFUSION
DENGUE VIRUS AND OTHER ARBOVIRUSES: A GLOBAL VIEW OF THE RISKS
HIV TRANSMISSION RISK AND EFFICACY OF SCREENING STRATEGIES ESTIMATED FROM DATA PROVIDED BY AN INTERNATIONAL NAT STUDY GROUP
COMPARISON OF HIV ASSAYS IN WINDOW PHASE AND ELITE CONTROLLER SAMPLES: VIRAL LOAD DISTRIBUTION AND IMPLICATIONS FOR TRANSMISSION RISK
WHICH HBV DNA SENSITIVITY LIMIT IS REQUIRED FOR THE SWISS BLOOD DONOR POPULATION
SPONTANEOUS HBV CLEARANCE AND OCCULT HBV INFECTION IN BLOOD DONORS WITH ANTI-HBC-ONLY PROFILES: CONTRIBUTION OF KIR AND SPECIFIC HLA-C GENE COMBINATIONS AND NK CELL ACTIVITY
PREOPERATIVE ANEMIA: THE NATA CONSENSUS
SURGICAL AND ANAESTHETIC MANAGEMENT OF ANAEMIA: PROS AND CONS OF CELL SALVAGE DEVICES
MINORITY BLOOD DONATION IN THE UNITED STATES
BLOOD DONATION PATTERNS AND CHALLENGES IN SOUTHERN AFRICA
NEW METHOD FOR RARE DONOR SCREENING USING A MULTIPLEX PCR WITH A POOL SYSTEM
SELFREPORTED MENTAL HEALTH PREDICTS DONATION FREQUENCY
BLOOD TRANSFUSION AND THE SOCIAL CONTRACT
THE ISBT CODE OF ETHICS AND THE ALTRUISTIC DONOR
GEODÁDIVAS - GEOGRAPHIC INFORMATION SYSTEM FOR BLOOD DONATION MANAGEMENT IN PORTUGAL
ISBT 128 - STANDARDIZED IDENTIFICATION FOR PRODUCTS OF HUMAN ORIGIN
LEGITIMATE MANAGEMENT INFORMATION SYSTEM OF BLOOD TRANSFUSION SERVICE OF INDONESIA UNDERWEB DESIGN (SIMUDDA)
BLOOD DONOR SCREENING BY NAT OR SEROLOGY SCREENING METHODS - WHICH STRATEGY IS MORE COST EFFECTIVENESS?
P-006
REDUCTION IN TIME CONSUMPTION FOR PACKING AND RETRIEVAL OF REPOSITORY BLOOD DONATION SAMPLES USING LEAN SIX SIGMA TOOLS
INTERNATIONAL COOPERATION PROGRAMMES AT EFS: FOR WHOM AND HOW ARE THEY HELPFUL?
CONTINUING MEDICAL EDUCATION AT NATIONAL INSTITUTE OF TRANSFUSION MEDICINE IN MACEDONIA - CURRENT SITUATION AND PERSPECTIVES
PICASSOS UNDER THE PAVILION: A CREATIVE APPROACH TO COMMUNITY AWARENESS
BLOODSAFE ELEARNING AUSTRALIA: 4 YEARS OF ONLINE TRANSFUSION EDUCATION
MANAGING RISK UNDER A NEW BLOOD POLICY
TRENDS IN INFECTIOUS DISEASES AMONG EUROPEAN DONORS: AN ANALYSIS OF COUNCIL OF EUROPE DATA COLLECTED BETWEEN 2001 AND 2008
HOW THE ECONOMIC CRISES COULD DECREASE BLOOD SAFETY
P-015
IMPROVING PRODUCTIVITY IN THE BLOOD SERVICE SUPPLY CHAIN
DEVELOPMENT AND IMPLEMENTATION OF STRATEGIES TO REDUCE RED CELL WASTAGE ACROSS PUBLIC AND PRIVATE HEALTHCARE SECTORS
EFFICACY OF BROAD-AREA INVENTORY CONTROL OF RED BLOOD CELL PRODUCTS IN 9-PREFECTURE-COMBINED AREA COMPARED WITH THAT IN 9 INDIVIDUAL PREFECTURES IN JAPAN
WASHED BLOOD: INCREASING CUSTOMER SATISFACTION ON THE WORK FLOW PROCESS
EXPERIENCE WITH REGIONAL BLOOD SERVICE UNDER THE NUCLEAR POWER PLANT ACCIDENTS CAUSED BY THE EAST JAPAN DISASTER
THE IMPACT OF ECONOMIC DEVELOPMENT ON BLOOD AGENCIES IN ZHEJIANG PROVINCE AND CHINA
BLOOD SUPPLY MANAGEMENT IN BLOOD TRANSFUSION INSTITUTE OF VOJVODINA
CLINICAL USE OF BLOOD IN GRADE-III HOSPITALS IN SHANGHAI
P-025
EFFECTIVE BLOOD DONATION MANAGEMENT
AUDITING FFP USAGE: USING PRE AND POST COAGULATION TESTING AS A TOOL
BLOOD COMPONENTS COLLECTION IN RUSSIAN FEDERATION
THE TREND AND ASSOCIATED FACTORS OF PLATELET COMPONENTS UTILIZATION IN TAIWAN
EFFECTS OF THE PROBLEMS FACED BY PATIENTS WITH THALASSEMIA DURING SUPPLY OF BLOOD AND BLOOD TRANSFUSION
PUBLIC PRIVATE PARTNERSHIP FOR STATEWIDE CONSOLIDATION AND CENTRALIZED INDIVIDUAL DONATION NUCLEIC ACID TESTING IN INDIA: KARNATAKA STATE EXPERIENCE
BLOOD MANAGEMENT IN THE GERMAN COMBAT SUPPORT HOSPITALS IN AFGHANISTAN
RATIONAL USE OF BLOOD COMPONENTS AND PRODUCTS IN GENERAL HOSPITAL CELJE FROM THE PERIOD 2007 TO 20,011
STRATEGIES FOR THE SAFETY OF PLATELET CONCENTRATE TRANSFUSIONS
ERROR MANAGEMENT IN BLOOD ESTABLISHMENTS: RESULTS OF 8-YEAR (2003–2010) EXPERIENCE AT CROATIAN INSTITUTE OF TRANSFUSION MEDICINE
PRODUCT RECALL - CROATIAN EXPERIENCE (2000–2010)
EVALUATING ADP, COLLAGEN AND EPINEPHRINE AS PLATELET AGONISTS FOR QUALITY CONTROL OF PLATELET COMPONENTS USING FLOW CYTOMETRY
ENSURING BLOOD/BLOOD PRODUCT QUALITY FOR BETTER TRANSFUSION OUTCOME
FIVE YEARS OF DEVELOPMENT OF THE EXTERNAL QUALITY ASSESSMENT PROGRAM OF IMMUNOHEMATOLOGY IN CHILE
COMPREHENSIVE ANALYSIS OF THE TECHNIQUES USED FOR TESTS IN BLOOD BANK LABORATORIES IN KOREA FOR RECENT 4 YEARS
DEVELOPMENT OF QUALITY INDICATORS FOR BLOOD SCREENING LABORATORY
OPTIMIZATION OF PREPARATION TECHNOLOGY OF INTERNAL QUALITY CONTROL PRODUCTS FOR BLOOD TRANSFUSION COMPATIBILITY TESTING
IMPLEMENTATION OF LEAN TO TRANSFUSION SERVICE IN THAILAND
EVALUATION OF ADAMRWBC SYSTEM FOR RESIDUAL LEUKOCYTE COUNT IN LEUKOREDUCED BLOOD COMPONENTS
USE OF EP15 A2 PROTOCOL FOR VERIFICATION OF PRECISION IN DONOR SCREENING TESTS
QUALITY IMPROVEMENT USING CLINICAL INDICATOR PARAMETERS IN THE FIELD OF TRANSFUSION
QUALITY INDICATORS TRENDS IN THE INSTITUTE OF TRANSFUSION MEDICINE SKOPJE, MACEDONIA
NONCONFORMITIES OF INCOMING MATERIALS IN CENTER FOR TRANSFUSION MEDICINE MARIBOR
CONTINUOUS IMPROVEMENT IN BLOOD BANK BASED ON THE KAIZEN METHODOLOGY
INTEGRATION OF STATISTICAL PROCESS CONTROL PROGRAM IN BLOOD BANK IT SYSTEM
HUMAN LEUKOCYTE ANTIGEN PROFICIENCY TESTING IN SOUTHERN ITALY
APPLICATION OF RISK MANAGEMENT METHODOLOGY IN IMPROVING THE PERFORMANCE OF BLOOD TRANSFUSION SERVICES
HOW CAN WE INCREASE THE RETURN OF LAPSED DONORS? RESULTS OF A RANDOMIZED, CONTROLLED INTERVENTION
WORKING TOGETHER TO MEET TODAY'S RECRUITMENT CHALLENGE-INVITING DEDICATED WHOLE BLOOD DONORS TO BECOME PLATELET DONORS
OPTIMIZING THE IRON STATUS OF REGULAR CHINESE BLOOD DONORS
PSYCHOLOGICAL DONOR REACTIONS TO EXCLUSION FOLLOWING FALSE POSITIVE OR INDETERMINATE SCREENING TEST RESULTS
MOTIVATIONS FOR DONATING AND TEST SEEKING AMONG PROSPECTIVE BLOOD DONORS IN BRAZIL
OFF-SITE THIRD PARTY TELEPHONE RECRUITING OF LAPSED DONORS IS A COST-EFFECTIVE METHOD TO INCREASE BLOOD DONATIONS IN GENERAL HOSPITALS
INTENTION TO DONATE BLOOD AND RISK BEHAVIOUR: A STUDY ON ADOLESCENTS
DONOR DEFERRAL IN VOLUNTARY NON-REMUNERATED BLOOD DONORS IN ALBANIA
FACEBOOKING TO START YOUR DAY SAVING LIVES
BARRIERS TO THE INITIAL CONVERSION AND CONTINUATION OF PLASMA DONATION
SCREENING OF DEFERRED BLOOD DONORS FOR HEMOGLOBINOPATHIES: IMPACT ANALYSIS IN A HIGH PREVALENCE ZONE
DONOR MOTIVATION IN XI'AN, CHINA: COMPARISON WITH CANADIAN DONORS
SOCIAL NETWORKS AS AN EFFECTIVE TOOL TO IMPROVE THE NUMBER OF VOLUNTEER BLOOD DONORS IN A THIRD LEVEL HOSPITAL'S BLOOD BANK IN MEXICO
P-071
MEASUREMENT OF A PRE-DONATION HEMOGLOBIN WITH A NON-INVASIVE METHODOLOGY
COMPARISON OF THREE METHODS FOR DETERMINATION OF HAEMOGLOBIN LEVELS IN PRE-DONATION SCREENING OF BLOOD DONORS
SERUM FERRITIN LEVELS FOR NORMAL HEMOGLOBIN BLOOD DONORS IN A KOREAN POPULATION
DETERRENTS AND MOTIVATING FACTORS FOR REPEAT DONATION AMONG FIRST-TIME PLATELET DONORS
DETERMINANTS OF DONOR RETURN AMONG CHINESE BLOOD DONORS
BLOOD DONOR RECRUITMENT AT VILA CENTRAL HOSPITAL BLOOD BANK PORT VILA, VANUATU
DONOR RECRUITEMENT IN COMMUNITIES WITH INADEQUATE HEALTH CARE SYSTEMS
BLOOD DONATIONS IN MACEDONIA-20 YEARS OF EXPERIENCE
BLOOD DONATION AND DONOR MOTIVATION IN OMAN -ACHIEVING 100% VOLUNTARY NON-REMUNERATED BLOOD DONATION
P-081
BLOOD DONORS DEFERRAL IN THE STATE OF QATAR: REASONS AND PROSPECTS
CAN SUPAR BE USED AS A BIOMARKER OF INFLAMMATION IN THE BLOOD DONOR QUALIFICATION PROCESS?
THE UMBILICAL CORD BLOOD IN GREECE
P-085
FEASIBILITY AND ACCEPTABILITY OF SMS TECHNOLOGY AMONG BLOOD DONORS IN NAIROBI
USE OF TEST CARDS FOR VIROLOGICAL PRE DONATION SCREENING:PRELIMINARY DATA
DONOR SATISFACTION IN THE CONTEXT OF ISO 9001:2008
ARE THE INCENTIVES INFLUENCING FACTOR FOR BLOOD DONOR RECRUITMENT IN MACEDONIA?
P-090
INTERDISCIPLINARY EDUCATION IN UNIVERSITY POPULATION: A STRATEGY FOR INCREASE SOCIAL SENSIBILITY AND VOLUNTARY BLOOD DONATION
VOLUNTARY BLOOD DONATION: UNDERSTANDING STUDENTS MOTIVATIONS AND ATTITUDES
EVALUATION OF RAPID METHODS FOR HEMOGLOBIN MEASUREMENT IN A BLOOD DONOR SETTING IN COTE D'IVOIRE
ANALYSIS OF SOCIO-DEMOGRAPHIC CHARACTERISTICS OF BLOOD DONORS IN THE DEPARTMENT OF TRANSFUSION MEDICINE - STRUMICA, REPUBLIC OF MACEDONIA IN 2011
IMPACT OF FACE TO FACE EDUCATION ON BLOOD DONATION
HEMOGLOBIN DISTRIBUTION OF BLOOD DONORS IN KOREA
ACHIEVING QUALITY OF BLOOD DONATION THROUGH CREATING AWARENESS AMONG BLOOD DONATION CAMPAIGN ORGANIZERS IN SRI LANKA
P-098
CHANGE OF THE STRUCTURE OF BLOOD DONORS IN THE REGIONAL CENTER TETOVO
BENEFITS FROM I A COMPUTERIZED BLOOD DONOR QUESTIONNAIRE
THE IMPACT OF SEVERAL NEW OUTBREAKS OF INFECTIOUS DISEASES IN EUROPE ON THE SELECTION OF OUR REGULAR AND NEW DONORS IN THE TRANSFUSION CENTRE IN GENERAL HOSPITAL CELJE
ACHIEVING 100% VOLUNTEER NON-REMUNERATED BLOOD DONATION IN THE COOK ISLANDS
SURVEY OF THE DEMOGRAPHIC CHANGES OF THE BLOOD DONORS IN SHIRAZ BLOOD SERVICE IN 2005–2011
IMPROVING THE SAFETY OF BLOOD PRODUCTS THROUGH STRINGENT DONOR SELECTION, PRE AND POST DONATION SCREENING OF BLOOD
BLOOD DONATION: LET'S TALK MORE
ASSESSMENT RESULT OF AN EDUCATIONAL INTERVENTION TO IMPROVE THE PERCEPTION OF VOLUNTARY BLOOD DONATION
NON-INVASIVE HEMOGLOBIN SENSOR PERFORMANCE IN ANEMIA SCREENING
CREATION OF AN ENABLING ENVIRONMENT FOR VOLUNTARY BLOOD DONATION IN PAKISTAN
STUDY OF BLOOD DONOR RETENTION AMONG AHVAZ MEDICAL STUDENTS IN 2010–2011
ARE REPEAT BLOOD DONORS BASED FROM A CLOSED SOCIAL COMMUNITY GROUP SAFER?
FIFTEEN CAUSES OF REJECTION OF CANDIDATES FOR BLOOD DONATION AT THE BANCO DE SANGRE DEL HOSPITAL CIVIL DE CULIACÁN Y CENTRO DE INVESTIGACIÓN Y DOCENCIA EN CIENCIAS DE LA SALUD FROM 2011 TO 2012
MOTIVATOR AND BARRIERS OF BLOOD DONATION AMONG FEMALE MEDICAL STUDENTS OF AHVAZ JUNDISHAPUR UNIVERSITY
TEMPORARY IMPACT OF BLOOD DONATION ON HAEMOGLOBIN, FERRITIN AND PHYSICAL PERFORMANCE IN MODERATELY PHYSICALLY ACTIVE MEN
INFECTIOUS DISEASE MARKERS IN PRESENTING DONORS DEFERRED FOR HIGHER RISK BEHAVIORS IN BRAZIL
INTERDONATION INTERVAL AND NUMBER OF PREVIOUS BLOOD DONATIONS DO NOT PREDICT FUTURE HEMOGLOBIN DEFERRAL AS WELL AS DONOR HEMOGLOBIN LEVEL AT LAST PRESENTATION
CHARACTERIZATION OF BLOOD DONORS WITH HIGH HAEMOGLOBIN CONCENTRATION
EVALUATION OF A NON INVASIVE PRE DONATION HEMOGLOBULIN SCREEINING
EVALUATION OF HEMATOLOGY ANALYZERS FOR THE DETERMINATION OF PLATELET COUNTS IN INTERSOL® APHERESIS PLATELETS
IMPLEMENTATION AND OPERATIONAL IMPACT OF COLLECTION AND MANUFACTURE OF APHERESIS PLATELETS STORED IN INTERSOL®
IMPROVED UTILIZATION OF APHERESIS TECHNOLOGY POTENTIAL THROUGH THE CONVERSION OF STANDARD PLATELET COLLECTIONS (SPC) TO PLASMA REDUCED PLATELET COLLECTIONS (PPC)
P-121
P-122
SCREENING FOR SICKLE CELL TRAIT IN BLOOD DONORS BY HEA BEADCHIPTM TEST
IN-VITRO STUDY OF THE QUALITY OF APHERESIS RED BLOOD CELLS (RBC) FOR PEDIATRIC USE, OBTAINED WITH THE CELL SEPARATOR TRIMA ACCEL® V6.0, STORED FOR 21 DAYS
P-125
POTENTIAL ADVERSE REACTIONS ASSOCIATED WITH APHERESIS MULTICOMPONENT (MAC) DONORS
A 1 YEAR COMPARATIVE ANALYSIS OF SINGLE NEEDLE PLATELETPHERESIS PROCEDURES PERFORMED ON TWO DIFFERENT CELL SEPARATORS
REDUCING PLATELET TARGET YIELD WITHOUT COMPROMISING PLATELET COLLECTION EFFICACY AND WORKFLOW AT A LOCAL UNIVERSITY HOSPITAL
P-129
CONTRIBUTION OF PLASMA COLLECTION ON TERRITORY TO REGIONAL BLOOD PRODUCT SELF SUFFICIENCY
VERIFICATION OF THE TRIMA ACCEL SYSTEM PERFORMANCE DURING THE GATHERING OF RED-CELL PACKAGES BY APHAERESIS
PERIPHERAL BLOOD STEM CELL HARVESTING WITH KABI COM.TEC
HIGH SCHOOL STUDENT DONATIONS IN SKOPJE, MACEDONIA - A 2 YEAR SURVEY
DONOR AWARENESS OF HEALTH EFFECTS OF BLOOD DONATION
CHEST PAIN REPORTED DURING OR AFTER BLOOD DONATION
EVALUATION OF AN ESTIMATED BLOOD VOLUME-BASED INTERVENTION TO DECREASE VASOVAGAL REACTIONS IN YOUNG BLOOD DONORS
YOUNG DONORS WITH HIGH BODY MASS INDEX AND LOW BLOOD VOLUME PREDISPOSED TO DONATION RELATED VASOVAGAL REACTIONS
INVESTIGATION OF DELAYED ADVERSE REACTIONS
RISK FACTORS FOR VASOVAGAL REACTIONS IN A COHORT OF FIRST-TIME DONORS
ADVERSE REACTIONS DURING WHOLE BLOOD DONATION - A 12 YEARS EXPERIENCE FROM A SINGLE CENTRE
DONOR ADVERSE REACTIONS IN POLISH BLOOD TRANSFUSION SERVICE
ADVERSE REACTIONS IN BLOOD DONORS: EXPERIENCE OF A PORTUGUESE BLOOD CENTRE
DONOR IRON STATUS MONITORING AND ONGOING DONOR MANAGEMENT
QUALITY OF COMPONENTS PREPARED USING THE REVEOS AUTOMATED BLOOD PROCESSING SYSTEM
EFFECT OF NITRIC OXIDE ON THE DEFORMABILITY OF RED BLOOD CELLS WITH DIFFERENT BUOYANT-DENSITIES
PERFORMANCE EVALUATION OF LEUCOFLEX LCRD AND LCRD2 FILTRATION AT 4°C OF UNITS OF RED CELL CONCENTRATES STORED UP TO 48 H AFTER COLLECTION AT 4°C
NON-DEHP BLOOD BAG SYSTEM CONSTITUTED WITH A NEW ADDITIVE SOLUTION CONTAINING VITAMIN E DERIVATIVE AND NON-LEACHABLE PVC MATERIAL
ONE HOUR RESTING EFFECT ON DAY 1 COULD BE MIMICKED BY 6 H RESTING ON 48 H STORED PCS BY INTERRUPTION OF AGITATION AT ROOM TEMPERATURE IN PERMEABLE BAGS
THE COMPARISON OF POLY(VINYL CHLORIDE) WITH DIFFERENT PLASTICIZER IN COMPLEMENT ACTIVATION
EVALUATION OF STABILITY OF COAGULATION FACTORS IN THAWED PLASMA DURING 5-DAY STORAGE AT 2–6°C
USE OF ITRACE DATA COLLECTION SYSTEM WITH PLASMAPHERESIS AUTOPHERESIS-C AT THE ETS CHARLEROI IN BELGIUM
ATREUS COMPONENT PROCESSING SYSTEM: A MARRIAGE OF CONVENIENCE OR A HAPPY ENDING
COMPARISON OF THREE DIFFERENT METHODS FOR DETECTION OF BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES
MULTIPLE EXPOSURES OF RED BLOOD CELL CONCENTRATES TO 30°C - IN VITRO QUALITY ASSESSMENT OF RED CELLS
COMPARISON OF THREE TOP AND BOTTOM DISPOSABLES TO PRODUCE LABILE BLOOD PRODUCTS: IMPACT ON QUALITY OF PRODUCTS AND ORGANIZATION OF PRODUCTION PROCESS IN THREE BLOOD BANK PRODUCTION CENTER
EVALUATION OF LEUKOREDUCTION EFFICIENCY AND IN VITRO STORAGE CHARACTERISITICS OF RED CELLS PROCESSED THROUGH A NEW RED CELL FILTRATION SYSTEM
SHOULD PREOPERATIVELY DONATED AUTOLOGOUS BLOOD WITH POSITIVE DIRECT ANTIGLOBULIN TESTS BE TRANSFUSED?
P-159
DEHP-FREE CONTAINERS FOR COLLECTION, PROCESSING AND STORAGE OF LABILE BLOOD PRODUCTS - COMPARATIVE EVALUATION OF FFPS
COMPARISON OF THREE DIFFERENT PRODUCTION PROCEDURES OF LEUCOREDUCED PLATELET CONCENTRATES OVER A STORAGE TIME OF 7 DAYS
THE INCIDENCE OF RED BLOOD CELL TRANSFUSION IN SOUTH AFRICA, 2010
VALIDATION OF THE OVERNIGHT HOLD OF WHOLE BLOOD AT ROOM TEMPERATURE AND THE BUFFY-COAT METHOD FOR THE PRODUCTION OF BLOOD COMPONENTS AT BLOOD CENTER OF PARA (HEMOPA)
STORAGE OF INTERIM PLATELET UNITS FOR 36 OR 48 H PRIOR TO POOLING
EVALUATION OF ARCHIMEDE AUTOMATED SEPARATOR FOR THE PREPARATION OF BLOOD COMPONENTS AT ETS CHARLEROI, BELGIUM
USE OF MIRASOL®-TREATED PLATELETS IN THE BLOOD BANK OF NAVARRA, SPAIN
SICKLE CELL ANAEMIA IN BLOOD DONORS DETECTED BY LEUCODEPLECTION
BACTERIAL GROWTH IN PLATELET ADDITIVE SOLUTION FOR USE WITH TRIMA ACCEL
A MULTICENTRE EFFORT TO STANDARDIZE THE FLOW CYTOMETRIC MEASUREMENT OF PLATELET-ASSOCIATED P-SELECTIN, CD62P
REDUCED SINGLE DONOR PLATELET (SDP) DOSING AND ASSOCIATION WITH DECREASED PLATELET REACTIONS
THROMBOLUX DONOR SCREENING FOR EFFECTIVE PLATELET TRANSFUSIONS
IN VITRO EVALUATION OF THE QUALITY OF RED BLOOD CELLS COLLECTED AND STORED IN SYSTEMS COMPLETELY FREE OF DEHP PLASTICIZED MATERIALS
DOUBLE DOSE PLATELETS PRODUCED FROM BC POOLS AND PATHOGEN INACTIVATED USING INTERCEPT PROVIDE ADEQUATE PATIENT SUPPORT WITH LOW ADVERSE EVENTS
PERCENTAGE RESIDUAL PLASMA OF PLATELET CONCENTRATES IN ADDITIVE SOLUTION AFFECTS IN VITRO QUALITY
LIPID INTERFERENCE IN PLATETET QUALITY TESTING
IN VITRO EVALUATION OF BUFFY COAT DERIVED PLATELET CONCENTRATES RESUSPENDED IN 70% PAS IV OR SSP+
RED CELL STORAGE WITH E-SOL 5 ADDITIVE SOLUTION IN STORAGE CONTAINERS WITH OR WITHOUT DEHP PLASTICIZER
EFFECT OF EXTENDED ROOM TEMPERATURE HOLD ON RED CELL CONCENTRATES STORED IN VARIOUS ADDITIVE SOLUTIONS
IN VITRO ANALYSIS QUALITY OF FROZEN APHERESIS RBCS STORAGE WITH 10-DAY POST THAW STORAGE IN SAG-M: COMPARISON BASED ON THE INITIAL LEUCODEPLETION
RANDOMIZED CROSS-OVER IN VITRO AND IN VIVO EVALUATION OF A PROTOTYPE ANAEROBIC CONDITIONING AND STORAGE SYSTEM VS STANDARD AEROBIC STORAGE
PLATELET CRYOPRESERVATION USING TREHALOSE AND PHOSPHATE AS CRYOPRESERVATION SOLUTION
FLOW CYTOMETRIC DETECTION AND CHARACTERIZATION OF PLATELET MICROPARTICLES IN PLATELET CONCENTRATE AT EXPIRY
TRIMA ACCEL V6 PRESS THROUGH VS GRAVITY DRAIN RBC LEUKOREDUCTION. HEMOLYSIS IN RBC UNITS STORED 42 DAYS IN SAGM
SERIAL CHANGES IN MORPHOLOGY AND BIOCHEMICAL MARKERS IN PLATELET PREPARATIONS WITH STORAGE
ASSESSMENT OF CELLULAR ACTIVATION MARKERS EXPRESSION AFTER LEUKODEPLETION OF PLATELETS CONCENTRATES
EFFICACY AND SAFETY OF SOLVENT/DETERGENT-FILTERED (S/D-F) CRYOPRECIPITATE PREPARED BY BLOOD ESTABLISHMENTS: 1-YEAR FOLLOW-UP
CAN THE RANGE OF PH BE A PREDICTIVE VALUE IN THE QUALITY OF PLATELET CONCENTRATES?
P-188
A COMBINATION FILTER FOR PRION AND LEUKOCYTE REDUCTION, THE RCC QUALITY AFTER DOUBLE FILTRATION
COMPARISON BETWEEN TWO MODELS OF BLOOD BAG SYSTEMS AND TWO GENERATIONS OF SEMI-AUTOMATED EXTRACTORS IN BLOOD PROCESSING
AN EXTERNAL PLATELET EVALUATION SCHEME USING INTERCEPT-TREATED PLATELET CONCENTRATES
THE INFLUENCE OF AUTOMATIC VALVE BREAKER, TEMPERATURE, PRESSURE AND TIME OF EXTRACTION ON COMPONENT QUALITY
THE EVALUATION OF QUALITY OF BLOOD COMPONENTS FROM WHOLE BLOOD HELD OVERNIGHT AT 4°C OR ROOM TEMPERATURE
COAGULATION FACTOR XIII ACTIVITY IN STORED FRESH FROZEN PLASMA AND PLASMA OF PACKED RED BLOOD CELL
COMPARISON OF TWO FILTERS FOR RED CELL LEUKOREDUCTION
A PROSPECTIVE STUDY TO ACCESS THE EFFECT OF LEUCOCYTE DEPLETED PACKED CELLS TRANSFUSION IN MULTIPLYTRANSFUSED THALASSEMIA MAJOR PATIENTS
EFFECT OF GLUCOSE SOLUTIONS ON ERYTHROCYTE MEMBRANE
MEASUREMENT OF EXACT RESIDUAL WHITE BLOOD CELL (WBC) CONTENTS: DETECTION OF WBC FRAGMENTATION IN LEUKOCYTE-REDUCED RED BLOOD CELLS AND LEUKOCYTEREDUCED RED BLOODS AND LEUKOCYTE-REDUCED PLATELETS
LOT RELEASE OF THE MANAGEMENT SYSTEM OF CHINESE BLOOD PRODUCTS SUPPLY 2007–2011
COMPARISON OF SOURCE PLASMA QUALITY IN THREE DIFFERENT APHERESIS SET-UPS
EFFICACY, SAFETY AND TOLERABILITY OF A SOLVENT/DETERGENT (S/D) TREATED AND PRION SAFEGUARDED TRANSFUSION PLASMA IN A RANDOMISED, CROSS-OVER, CLINICAL TRIAL IN HEALTHY VOLUNTEERS
P-202
QUALITY OF OCTAPLASLG® BASED ON VARIANT PLASMA SOURCES
PURIFICATION OF HUMAN α 1-ANTITRYPSIN WITH HIGH SPECIFIC ACTIVITY USING A NEW PROCEDURE
ISOLATION OF IGA-ENRICHED COMPONENT FROM POOLED HUMAN PLASMA
UNIVERSAL POOLED PLASMA (UNIPLAS®) DOES NOT INDUCE COMPLEMENT-MEDIATED HEMOLYSIS OF HUMAN RED BLOOD CELLS IN VITRO
SIMPLE METHOD FOR PREPARATION OF HUMAN FACTOR VIII CONCENTRATE FROM FRESH FROZEN PLASMA
PREPARATION OF HUMAN COAGULATION FACTOR VII CONCENTRATE FROM FRESH FROZEN PLASMA BY USING QAE-SEPHADEX CHROMATOGRAPHY
HOW IMPORTANT IS THE TIME BETWEEN COLLECTION AND SEPARATION OF WHOLE BLOOD UNITS ON THE QUALITY?
COLLABORATIVE STUDY FOR THE ESTABLISHMENT OF KOREAN STANDARD FOR BLOOD COAGULATION FACTOR IX CONCENTRATE
STUDY OF CAPILLARY ZONE ELECTROPHORESIS FOR PLASMA PROTEIN MIXTURE ANALYSIS
EFFECT OF GEL EQUILIBRATION CONDITIONS ON YIELD OF FOUR COAGULATION FACTORS IN PROTHROMBIN COMPLEX CONCENTRATES PRODUCTION
CONSTRUCTION OF HIGH-CAPACITY HUMAN RIBOSOME DISPLAY SINGLE CHAIN FV LIBRARY AND ANALYSIS OF ITS DIVERSITY
EFFICACY AND SAFETY OF SOLVENT/DETERGENT-FILTERED (S/D-F) PLASMA PREPARED BY BLOOD ESTABLISHMENTS: 1-YEAR FOLLOW-UP
RBCS DERIVED FROM DIFFERENT WHOLE BLOOD HOLD CONDITIONS ARE COMPATIBLE WITH THE S-303 TREATMENT SYSTEM
FRANGIBLE ANCHOR EFFECTOR LINKER COMPOUNDS STRUCTURE OPTIMIZATION FOR PATHOGEN INACTIVATION IN WHOLE BLOOD
THE MIRASOL® SYSTEM FOR WHOLE BLOOD, AN ALTERNATIVE TO GAMMA-IRRADIATION IN THE PREVENTION OF TA-GVHD?
IMPACT OF MIRASOL® PRT TREATMENT ON MITOCHONDRIAL DNA IN PLATELETS BY A REAL-TIME PCR INHIBITION METHOD
MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) TREATMENT OF P. YOELII CONTAMINATED PLASMA NEUTRALIZES PARASITE IN A MURINE MODEL FOR MALARIA
EFFICIENT INACTIVATION OF DENGUE VIRUS BY MINI-POOL SOLVENT/DETERGENT TREATMENT OF PLASMA AND CRYOPRECIPITATE
BACTERIAL CONTAMINATION OF PLATELETS CONCENTRATE: COULD RESVERATROL BE AN ALTERNATIVE TO BACTERIA REDUCTION?
INACTIVATION OF PLASMODIUM FALCIPARUM-INFECTED WHOLE BLOOD WITH MIRASOL
EVALUATION OF PATHOGEN REDUCTION SYSTEMS TO INACTIVATE DENGUE AND CHIKUNGUNYA VIRUSES IN APHERESIS PLATELETS SUSPENDED IN PLASMA
FVIII AND FIBRINOGEN RECOVERY AFTER THERAFLEX MBPLASMA PROCCEDURE FOLLOWING PLASMA SOURCE AND TREATMENT TIME
IN VITRO VALIDATION OF THE S-303 TREATMENT SYSTEM
IN VITRO ANALYSIS OF PROTEINS IN FRESH FROZEN PLASMA OBTAINED FROM WHOLE BLOOD DONATIONS AND PREPARED WITH THREE PHOTOCHEMICAL TREATMENTS
ANNEXIN V BINDING DURING STORAGE OF PLATELET CONCENTRATE FROM BUFFY COAT, AFTER PATHOGEN REDUCTION TREATMENTS
QUALITY OF PRION REDUCED AND CONVENTIONAL RED CELLS AFTER TREATMENT WITH THE S-303 SYSTEM FOR PATHOGEN INACTIVATION
WHOLE BLOOD PATHOGEN INACTIVATION AND STORAGE USING THE S-303 TREATMENT SYSTEM
MAXIMIZING FVIII ACTIVITY IN PLASMA BEFORE AND DURING INTERCEPT TREATMENT
COMPLETE INACTIVATION OF HIGH BACTERIAL TITER CHALLENGES IS ACHIEVED WITH THE INTERCEPT PI SYSTEM
WHOLE BLOOD FILTER RZ-2000 EFFICIENTLY LEUKODEPLETES POOLED PLASMA PRIOR TO PATHOGEN INACTIVATION WITH INTERCEPT
THE GENOTOXICITY STUDY OF YWW007, A NEW PHOTOSENSITIZER DERIVED FROM PHENOTHIAZINE
VALIDATION OF HIV INACTIVATION CAPACITY OF THE THERAFLEX MB-PLASMA SYSTEM WITH HIGH SENSITIVITY
ROUTINE PRODUCTION AND CLINICAL USE OF MIRASOL®-PLATELETS AND FFP AT THE REGIONAL BTS WARSAW
BACTERIAL GROWTH AND BIOFILM FORMATION IN PLATELET POOLS THAT HAVE BEEN INOCULATED AFTER PATHOGEN INACTIVATION TREATMENT
VIRUS REMOVAL BY VIRAL AGGREGATION WITH LARGER PORE-SIZE NANOFILTER
OUTPUT OF HIGH YIELD PLATELET (PLT) APHERESIS BEFORE AND AFTER PATHOGEN REDUCTION WITH AMOTOSALEN AND UVA: TRIPLE DOSE PLT ARE CHALLENGING, BUT STILL UP-TODATE
STORAGE OF PACKED RED BLOOD CELLS DERIVED FROM WHOLE BLOOD TREATED WITH THE MIRASOL® SYSTEM
COMPARISON OF TWO DIFFERENT INACTIVATION METHODS; OUR OWN EXPERIENCE
TRANSFUSION OF PATHOGEN INACTIVATED BLOOD PRODUCTS USING RIBOFLAVIN AND ULTRAVIOLET LIGHT - 2 YEARS OF EXPERIENCE
THE OBSERVATION OF THE EFFECT OF METHYLENE BLUE PHOTOCHEMICAL VIRUS INACTIVATION ON THE PLASMA WITH HBV INFECTION IN WINDOW PERIOD BY NUCLEIC ACID TEST
VIRAL REDUCTION OF INTRACELLULAR HIV USING THE MIRASOL® SYSTEM FOR WHOLE BLOOD
EVALUATION OF APOPTOSIS MARKER AT THE MEMBRANE SURFACE OF RESIDUAL LYMPHOCYTES IN PHOTOCHEMICALY TREATED PLATELET CONCENTRATES
MICROPARTICLES FROM STORED RED BLOOD CELLS INDUCE THROMBIN GENERATION
THE NETHERLANDS EXPERIENCE WITH FROZEN -80°C RED CELLS, PLASMA AND PLATELETS IN COMBAT CASUALTY CARE
BACTERICIDAL ACTIVITY OF PLATELET-POOR-PLASMA, PLATELET-RICH-PLASMA, PLATELET GEL AND SOLVENT/DETERGENT-TREATED PLATELET LYSATE: INTEREST FOR WOUND HEALING
CONSTRUCTION OF THE EXPRESSION VECTOR FOR RECOMBINANT HUMAN COAGULATION FACTOR VII
THE EFFECT OF PROSTAGLANDINE E1 ON PLATELET AGGREGATION DURING PREPARATION OF LYOPHILIZED HUMAN PLATELET
THE AUSTRALIAN EXPERIENCE WITH DEEP FROZEN BLOOD PRODUCTS
PREPARATION OF HEPARIN-MODIFIED PBT NONWOVEN FABRICS AND THEIR APPLICATION AS LEUKOCYTE REMOVAL FILTERS
PROLIFERATION ACTIVITY OF EXPIRED PLATELETS
PERFORMANCE CHARACTERISTICS OF THE PROCLEIX ULTRIO ELITE ASSAY ON THE FULLY AUTOMATED PROCLEIX PANTHER INSTRUMENT PLATFORM
PERFORMANCE CHARACTERISTICS OF THE PROCLEIX PARVO/HAV ASSAY ON THE PROCLEIX TIGRIS SYSTEM, A DUPLEX ASSAY FOR QUANTITATIVE DETECTION OF PARVOVIRUS B19 AND QUALITATIVE DETECTION OF HEPATITIS A VIRUS
REINFORCEMENT OF THE TRANSFUSION SAFETY FOR BLOOD-BORNE VIRUSES ON AFRICAN CONTINENT THROUGH A MULTINATIONAL STUDY
EVALUATION OF A NATIONAL QUALITY CONTROL PROGRAM FOR MALAYSIAN BLOOD SCREENING LABORATORIES
IMPACT OF INDIVIDUAL DONOR NUCLEIC-ACID AMPLIFICATION TESTING OF BLOOD DONORS IN INTERDICTING THE TRANSMISSION OF TRANSFUSION TRANSMITTED HIV, HEPATITIS B AND HEPATITIS C IN INDIA
INDONESIA INDIVIDUAL DONATION BLOOD SCREENING EXPERIENCE WITH THE IMPROVED SENSITIVITY ULTRIOPLUS® ® REAGENT ON PROCLEIX® TIGRIS® SYSTEM FOR THE DETECTION OF HIV-1, HCV AND HBV NUCLEIC ACIDS
IMPROVING BLOOD DONOR SCREENING BY NUCLEIC ACID TECHNOLOGY/UAE.EXPERIENCE
VIRAL TRANSMISSION RISK ASSESSMENT ON INDIVIDUALDONATION NUCLEIC ACID TESTING IN KUALA LUMPUR, MALAYSIA
P-261
COMMUTABILITY OF INACTIVATED VIRAL STANDARDS USED FOR EXTERNAL QUALITY CONTROL OF NUCLEIC ACID AMPLIFICATION TESTING OF BLOOD DONATIONS
RESULTS OF CONFIRMATORY TESTING OF ARCHITECT SYPHILIS TP REPEATEDLY REACTIVE DONATIONS IN CROATIA IN 2011
NAT POSITIVE DETECTION IN BLOOD DONOR AFTER 6 DAYS RISK SITUATION EXPOSITION
INITIAL EXPERIENCE OF BLOOD SCREENING USING NUCLEIC ACID TESTING (NAT) IN POOLS OF 6 IN A TERTIARY CARE HOSPITAL, NEW DELHI, INDIA
PERFORMANCE OF NEW DIASORIN LIAISON® XL MUREX HBSAG QUANT IMMUNOASSAY FOR DETECTION OF HBSAG IN HUMAN SERUM AND PLASMA
NAT YIELD IN A UNIVERSITY BLOOD BANK OF BUENOS AIRES
IMPLEMENTATION OF THE FULLY AUTOMATED, MULTIPLEXED NUCLEIC ACID TESTING (NAT) AT QINGDAO BLOOD CENTRE, CHINA
OUTCOME OF NAT IMPLEMENTATION IN A REGIONAL BLOOD CENTER IN ARGENTINA
COMPARISON OF SYPHILIS REJECTION RATE AND DONOR DEFERRAL RATE AFTER THE IMPLEMENTATION OF SYPHILIS TESTING USING TPPA TEST
HIV PREVALENCE IN FIRST-TIME AND REPEAT BLOOD DONATIONS IN ZIMBABWE, IMPACT ON BLOOD SAFETY
EVALUATION OF NAT IMPLEMENTATION IN THE HEMOTHERAPY SERVICE OF INCA/RJ, BRAZIL
IMPLEMENTATION OF NUCLEIC ACID TECHNOLOGY (NAT) A MULTICENTER RETROSPECTIVE STUDY IN THE INSTITUTO MEXICANO DEL SEGURO SOCIAL FROM 2008 TO 2011
RESULTS OF NAT IN TERTIARY CARE HOSPITAL IN INDIA AND INTERESTING CASE REPORT OF NAT-YIELD USING PROPOSED ALGORITHM
P-275
USE OF PROCLEIX ULTRIO NUCLEIC ACID TESTING ASSAY FOR HIV-1/HCV/HBV SCREENING IN INDIA
HTLV 1/2 PREVALENCE AMONG IRANIAN BLOOD DONORS, 2009–2011
INTEGRAL MEDICAL SERVICES AND SANGUINEOUS SAFETY INSTITUTO MEXICANO DEL SEGURO SOCIAL EXPERIENCE
FREQUENCY AND EPIDEMIOLOGICAL PROFILE OF BLOOD DONORS INFECTED BY HTLV-I/II
THE ID-NAT IMPLEMENTATION EXPERIENCE IN THE BLOOD BANK OF MEXICO's NORTH EASTERN REGION
COMPARISON OF HIV, HEPATITIS B, HEPATITIS C AND SYPHILIS SEROPREVALENCE AMONG DONORS BETWEEN HOSPITAL BASED AND COMMUNITY BASED BLOOD CENTER IN YOGYAKARTA INDONESIA
TRUE INFECTIOUS STATUS OF BLOOD DONORS WITH ANTI HEPATITIS C (HCV) ENZYME IMMUNE ASSAY (EIA) REACTIVE RESULTS: A PROSPECTIVE STUDY
CMV INFECTION IN IMMUNOCOMPROMISED AND MULTITRANSFUSED PATIENTS
TRANSFUSION TRANSMITTED INFECTIONS AMONG BLOOD DONORS OF A TEACHING HOSPITAL IN ISLAMABAD, PAKISTAN
HIV AND HCV INCIDENCE ESTIMATION IN FIRST TIME BLOOD DONORS
PREVALENCE OF TRANSFUSION TRANSMISSIBLE INFECTIONS AMONG BLOOD DONORS IN KATHMANDU, NEPAL
PREVALENCE OF HEPATITIS B AND HEPATITIS C VIRUSES IN BLOOD DONORS AT THE CLINICAL HOSPITAL CENTER ‘DR DRAGISA MISOVIC - DEDINJE’
P-288
P-289
EXPERIENCE WITH THE EVIDENCE OF NUCLEIC ACIDS (NAT) IN BLOOD DONORS FROM THE NATIONAL INSTITUTE OF PEDIATRICS
EPIDEMIOLOGICAL SITUATION IN VERACRUZ, MEXICO ON BLOOD TRANSFUSION TRANSMITTED INFECTIONS AND MOLECULAR DIAGNOSIS APPLICATION
PERFORMANCE OF TRIPLEX NUCLEIC ACID TESTING IN DALIAN BLOOD DONORS
AN ABORTIVE WILD-TYPE HBV INFECTION IN A BLOOD DONOR APPARENTLY NON-RESPONDER TO HBV IMMUNIZATION: ANOTHER CASE OF AN ACUTE PRIMARY OCCULT HBV INFECTION
ARE HEPATITIS B VIRUS ESCAPE MUTANTS A RISK TO BLOOD SAFETY
ENHANCEMENT OF HBV NAT YIELD RATE AFTER INTRODUCTION OF THE ULTRIO PLUS ASSAY
ENHANCED HBV DETECTION IN HONG KONG BLOOD DONORS WITH THE SECOND GENERATION TRIPLEX TRANSCRIPTION MEDIATED AMPLIFICATION ASSAY
SPLICED AND UNSPLICED HEPATITIS B VIRUS VARIANTS OF GENOTYPE A-E: IMPLICATIONS FOR BIOLOGY AND QUANTIFICATION OF HBV GENOME
A STUDY ON NUCLEIC ACID TESTING BY TMA TECHNOLOGY FOR HBV, HCV AND HIV-1 IN BLOOD SCREENING
PLASMA PROTEOMIC ANALYSIS IN BLOOD DONORS WITH OCCULT HEPATITIS B VIRUS INFECTION
COMPARISON OF PROCLEIX ULTRIO ASSAY AND NESTED-PCR FOR DETECTION OF OCCULT HBV INFECTION
ALGORITHM TO USE HEPATITIS CORE ANTIBODY AND/OR IDNAT TO ENHANCE THE BLOOD SAFETY IN TERTIARY CARE HOSPITAL HBV FOR SCREENING
LOW EFFICACY OF CURRENT NUCLEIC ACID TESTING (NAT) ASSAY FOR THE IDENTIFICATION OF OCCULT HBV INFECTION (OBI) AND CONSEQUENCES FOR SAFETY OF BLOOD SUPPLY IN ITALY
PREVALENCE AND DEMOGRAPHIC DETERMINANTS OF HEPATITIS B VIRUS IN FIRST-TIME U.S. BLOOD DONORS, 2004–2009
SURVEILLANCE FOR OCCULT HBV INFECTION AND HBSAG VARIANTS IN BLOOD DONORS
THE PREVALENCE OF HBSAG AND ANTI-HCV IN BLOOD DONORS OF TIRANA
INCIDENCE OF HBV INFECTION IN RELATION TO THE AGE IN A BLOOD DONOR POPULATION IN ITALY
HBV DNA SCREENING IN HEPATITIS B HIGH-PREVALENCE AREAS CAN FURTHER ENSURE THE SAFETY OF BLOOD TRANSFUSION
PREVALENCE AND INCIDENCE OF HBV AND HCV AT FIVE CHINESE BLOOD CENTERS, 2008–2010
FOUR YEARS’ SURVEILLANCE OF OCCULT HEPATITIS B IN GREEK BLOOD DONORS
MOLECULAR CHARACTERIZATION OF OCCULT HEPATITIS B INFECTION IN BLOOD DONORS FROM MEXICO
HBV NAT RESULTS FROM PILOT NUCLEIC ACID TESTING AT A CENTRAL BLOOD BANK IN INDONESIA
DETECTION OF HBSAG IN RECENTLY VACCINATED BLOOD DONORS
NAT EXPERIENCE FOR HEPATITIS B INFECTION IN AN ARGENTINEAN BLOOD BANK
A WINDOW-PERIOD HBV NAT DONATION FROM A VACCINATED DONOR
FREQUENCY OF PRECORE MUTATION IN HBV INFECTED BLOOD DONORS AND PATIENTS
THE DETECTION OF HBV DNA G1896A POINT MUTATION WITH LOCKED NUCLEIC ACID TECHNOLOGY COMBINED WITH MOLECULAR BEACON
IMPROVEMENT BLOOD TESTING STRATEGY OF HBSAG BY USING OF ROC CURVES
IMPACT OF HBV VACCINATION ON PREVALENCE OF HEPATITIS B IN TEHRAN BLOOD DONORS
A NAT-ONLY HBV POSITIVE DONATION: POSSIBLY A BREAKTHROUGH SUBCLINICAL INFECTION IN A HBV VACCINATED BLOOD DONOR
STUDY ON PRE-C/C GENE MUTATION OF OCCULT HEPATITIS B VIRUS FROM BLOOD DONORS
EVALUATION OF HBV VIREMIA IN HBEAB POSITIVE CHB PATIENTS
PERFORMANCE ASSESSMENT OF A NEW ANTI-HCV ASSAY
DEVELOPMENT OF A REVERSE-TRANSCRIPTION ISOTHERMAL AMPLIFICATION ASSAY FOR RAPID DETECTION AND GENOTYPING OF HEPATITIS C VIRUS INFECTION IN BLOOD
GENERATION AND CHARACTERIZATION OF MOUSE MONOCLONAL ANTIBODIES RECOGNIZING EPITOPES OF NONSTRUCTURAL PROTEIN 3 IN HCV INFECTED CELLS
IL - 28B GENETIC VARIATION AND ITS ASSOCIATION WITH SUSCEPTIBILITY TO HEPATITIS C VIRUS OF CHINESE BLOOD DONORS
RELIABLE HCV TESTING WITH A NEW ANTIBODY ASSAY: ENZYGNOST ANTI-HCV 4.0*
COMPARISON OF TWO COMMERCIAL SCREENING ASSAYS FOR DIAGNOSIS OF HEPATITIS C
EVALUATION OF HCV REACTIVE DONORS ACCORDING TO TYPE OF DONOR, GENDER (SEX) AND AGE GROUPS AT SHEBIN EL KOM REGIONAL BLOOD TRANSFUSION CENTER (RBTC) (FROM JANUARY 2011 TO DECEMBER 2011)
EIA HCV AG/AC UTILITIES IN BLOOD DONORS TESTING
RISK FACTORS FOR HIV IN BRAZILIAN BLOOD DONORS - A PRELIMINARY ANALYSIS
INVESTIGATION OF CASES OF SUSPECTED TRANSFUSION TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS REPORTED TO THE AMERICAN RED CROSS
A SURVEILLANCE OF HIV-1 DRUG RESISTANCE MUTATIONS AMONG HIV-1 INFECTED VOLUNTARY BLOOD DONORS AND CLINICAL PATIENTS IN CHENGDU, SICHUAN, CHINA
EVALUATION OF GEENIUS HIV 1/2 CONFIRMATORY ASSAY
SOCIAL PROFILE OF REPEAT REACTIVE DONORS FOR HIV 1/2 MARKERS IN UKRAINE DURING 2008–2010
DIAGNOSTIC SENSITIVITY PERFORMANCE OF THE MPD HIV BLOT 2.2
RISK BEHAVIOURS OF MSM AND BLOOD SAFETY: DONATING OR TESTING? THE EUROPEAN MSM INTERNET SURVEY (EMIS) IN GREECE
RELATION OF THE VIRAL LOAD AND CYTOMETRICS OF FLOW IN SEROPOSITIVE PATIENTS OF THE PAEDIATRICS NATIONAL INSTITUTE OF MEXICO
PREVALENCE OF HIV INFECTION AMONG PATIENT ATTENDING DELTA STATE UNIVERSITY TEACHING HOSPITAL, OGHARA DURING THE PERIOD OF JANUARY 2011 TO APRIL 2011
THE LACK OF THE ‘BLOOD DONOR CANDIDATE’ STATUS AND ITS INFLUENCE ON THE DETECTIONS OF THE HIV INFECTIONS IN THE REGIONAL BLOOD DONOR CENTRE IN POZNA
PRELEVANCE OF HIV INFECTION IN OUR BLOOD DONOR POPULATION
THE FIRST YEAR OF BACTERIAL SCREENING OF PLATELET COMPONENTS - THE ENGLISH EXPERIENCE
DETECTION OF ASYMPTOMATIC ESCHERICHIA COLI BACTEREMIA IN A BLOOD DONOR BY BACT/ALERT: A CASE REPORT STUDY
RAPID DETECTION OF BACTERIAL CONTAMINATION OF PLATELET-RICH PLASMA-DERIVED PLATELET CONCENTRATES USING FLOW CYTOMETRY
ROUTINE BACTERIAL SCREENING IN PLATELETS WITH A GENERIC 16S DNA NAT SYSTEM ON ZELOS X100 PLATFORM AND BACTIFLOW (AES, CHEMUNEX)
MICROBIAL CONTAMINATION OF PERIPHERAL BLOOD PROGENITOR CELL PRODUCTS: A CHINESE BLOOD CENTER's INVESTIGATION
ARE THERE RECOGNIZED BENEFIT FROM PAIRED SYPHILIS ANTIBODY PLUS CONFIRMATORY TESTING OF BLOOD DONORS?
STREPTOCOCCUS SANGUINIS -INDUCED CYTOKINE RELEASE FROM PLATELETS
PROSPECTIVE EVALUATION OF 2% (W/V) ALCOHOLIC CHLORHEXIDINE GLUCONATE AS AN ANTISEPTIC AGENT FOR BLOOD DONOR ARM PREPARATION
MICROBIOLOGICAL ENVIRONMENTAL MONITORING IN BLOOD COMPONENTS PRODUCTION DEPARTMENT AND BLOOD COLLECTION DEPARTMENT
BRUCELLOSIS SURVEY IN FIVE MOST PREVALENT REGIONS ON IRANIAN BLOOD DONORS
ENVIRONMENTAL SURVEILLANCE IN BLOOD BANK: VALUABLE TOOL FOR MONITORING RISK OF MICROBIAL CONTAMINATION OF BLOOD COMPONENTS
BACTERIAL CONTAMINATION
COST-EFFECTIVENESS OF SCREENING BLOOD DONORS FOR CHRONIC Q FEVER IN THE NETHERLANDS
TRYPANOSOMA CRUZI ANTIBODY SCREENING IN U.S. BLOOD DONORS: FOUR-YEAR EXPERIENCE AND CHARACTERIZATION OF ANTIBODY REACTIVE DONORS
REFERENCE VALUES FOR LEISHMANIA INFANTUM PARASITEMIA IN ASYMPTOMATIC INFECTED BLOOD DONORS AND LEISHMANIASIS PATIENTS FROM AN ENDEMIC REGION
TEN-YEAR INCIDENCE OF CHAGAS CARDIOMYOPATHY AMONG ASYMPTOMATIC T. CRUZI SEROPOSITIVE, FORMER BLOOD DONORS
TRYPANOSOMA CRUZI INFECTION IN NORTH AMERICA AND SPAIN: ESTIMATING THE RISK OF TRANSFUSION TRANSMISSION
CYTOKINE PROFILE IN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION IN BLOOD DONORS
SEROLOGICAL SCREENING FOR CHAGAS DISEASE IN SWISS BLOOD DONORS
T. CRUZI REMOVAL FILTER DEVELOPMENT FOR WHOLE BLOOD
MOLECULAR CHARACTERIZATION OF ENZYMES INVOLVED IN OXIDATIVE STRESS ON CHAGAS DISEASE
SEROPREVALENCE OF TRYPANOSOMA CRUZI ANTIBODIES IN BLOOD DONORS IN CENTRAL BLOOD BANK OF CENTRO MÉDICO NACIONAL LA RAZA, MÉXICO CITY
CHAGAS DISEASE IN MEXICAN BLOOD DONORS
EVALUATION AND UTILITY OF MALARIA ANITBODY AND MALARIA ANTIGEN KITS IN BLOOD DONORS
EVALUATION OF LEUCODEPLETION AND PRION REDUCTION FILTERS FOR ENDOGENOUS INFECTIVITY REMOVAL FROM BLOOD PRODUCT IN A SHEEP SCRAPIE EXPERIMENTAL MODEL
CORRELATION BETWEEN THE LEVELS OF WNV VIRAL LOAD, MODULATION OF CYTOKINES/CHEMOKINES AND CLINICAL DISEASE IN WNV+ BLOOD DONORS
SEROLOGIC AND MOLECULAR EVIDENCE OF A PLAUSIBLE TRANSMISSION OF HEPATITIS E VIRUS (HEV) THROUGH POOLED PLASMA
AN EVIDENCE-BASED EVALUATION OF THE RISK POSED BY ROSS RIVER VIRUS TO THE SAFETY OF THE AUSTRALIAN BLOOD SUPPLY
COMPARING THE YIELD OF DENGUE VIREMIC BLOOD DONATIONS USING NS1 ANTIGEN (AG) AND NUCLEIC ACID TESTING (NAT)
ARE AUSTRALIAN BLOOD DONORS EXPOSED TO DENGUE VIRUS DURING LOCAL OUTBREAKS?
ESTIMATING THE TRANSFUSION TRANSMISSION RISKS OF Q FEVER IN THE NETHERLANDS
INACTIVATION OF VARIOUS BACTERIA, VIRUSES AND PARASITES IN RED BLOOD CELLS BY TREATMENT WITH S-303
EMERGING INFECTIOUS DISEASE RISKS FOR TRANSFUSION PRACTICE: A MODELING APPROACH
PHYLOGENETIC AND TIME-SCALE ANALYSIS OF DENGUE VIRUS TYPES 1 AND 4 CIRCULATING IN BLOOD DONORS FROM PUERTO RICO AND KEY WEST, FLORIDA, DURING 2010 EPIDEMICS
DYNAMICS IN EVOLUTION OF WEST NILE VIRUS FROM HUMAN INFECTIONS IN THE US AFTER 2006
IMPLEMENTATION OF WEST NILE VIRUS NAT SCREENING IN GREEK BLOOD DONORS
CAPT PRION REMOVAL FILTER DELAYS ONSET OF ATYPICAL NEUROLOGICAL DISEASE OBSERVED IN PRIMATES EXPOSED TO V-CJD INFECTED RED BLOOD CELL CONCENTRATES
PHOTOCHEMICAL INACTIVATION OF USUTU VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM FOR PLATELETS
PILOT STUDY OF HEPATITIS E VIRUS DETECTION IN BLOOD DONORS WITH A MULTIPLEX MINI POOL NAT ASSAY ON ZELOS X100 PLATFORM
WEST NILE VIRUS IN SPAIN. YEARS 2010 AND 2011
DEVELOPMENT OF P-CAPT FILTER FOR REDUCTION OF PRION INFECTIVITY AND VCJD TRANSMISSION OF RED BLOOD CELL CONCENTRATES
DETERMINATION OF IGG/IGM ANTI DENGUE VIRUS ANTIBODIES IN BLOOD BLANKS OF TWO DIFFERENT GEOGRAPHIC AEREAS OF ARGENTINA, THE CITY OF BUENOS AIRES VS THE CITY OF SANTO TOME, CORRIENTES
POST-TRANSFUSION TRANSMISSION OF HEPATITIS A VIRUS (HAV)
THE SEROPREVALENCE OF IGG ANTI-HAV ANTIBODIES AMONG SLOVENIAN BLOOD DONORS
BLOOD DONATIONS FROM POLAND AND GERMANY WERE NEGATIVE FOR XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS (XMRV)
DENGUE NS1 ANTIGEN DETECTION AMONG SELECTED BLOOD DONORS IN A DENGUE-ENDEMIC PROVINCE IN NORTHERN PHILIPPINES
EVALUATION OF DENGUE VIRUS INFECTION FREQUENCY IN VOLUNTARY DONORS IN SISTAN AND BALUCHESTAN PROVINCE
THE EFFECT OF PATHOGEN REDUCTION TECHNOLOGY (MIRASOL) ON THE INFECTIVITY OF DENUGE VIRUSES
DEVELOPMENT OF NOVEL MONOCLONAL ANTIBODIES TO MOUSE RED CELLS FOR STUDYING EARLY ERYTHROPOIESIS IN MOUSE MODELS
LOW-GRADE INFLAMMATION AND HAEMOGLOBIN LEVELS IN DANISH BLOOD DONORS
IMPROVING SKILL IN SEROLOGIC REACTION GRADING WITH A + B KODECYTES
NOVEL APPLICATION OF GOLD NANOPARTICLES FOR ANTIBODY SCREENING TEST
C3B DEPOSITION ON HUMAN ERYTHROCYTES OF DIFFERENT AGES
PHYLOGENESIS OF AFRICAN RHD CLUSTERS: IDENTIFICATION OF RELATED VARIANTS AND ANTI-D IMMUNIZATION IN ITALY
CHALLENGES FACED BY A TRANSFUSION SERVICE IN A DEVELOPING COUNTRY TO MEET THE NEEDS OF RARE BLOOD TYPES: THE IMPORTANCE OF MAINTAINING A RARE DONOR PANEL
RED BLOOD CELLS PRESERVATION FOR HEMAGGLUTINATION ASSAYS BY THE DROPLET FREEZING WITH POLYVINYLPYRROLIDONE
BIOPATH EXPERIENCE WITH IH-1000: INTEGRATION SOLUTIONS AND PERFORMANCE CHARACTERISTICS IN A LARGE LABORATORY TESTING CENTER
THE CURIOUS CASE OF THE MISSING S ANTIGEN
SOLUBLE AND CELLULAR ABH ANTIGENS IN SEMEN. ALTERNATIVE TOOLS TO STUDY HUMAN INFERTILITY
RESULTS OF RHD TYPING IN A WEAK D RECIPIENT. ANALYSIS OF NATIONAL EXTERNAL QUALITY ASSESSMENT PROGRAM EXERCISE
DEL RBC TRANSFUSION SHOULD BE AVOIDED IN PARTICULAR BLOOD RECIPIENTS IN EAST ASIAN AS ALLOSENSITIZATION AND INEFFECTIVE TREATMENT
ABO GROUP SUSCEPTIBILITY TO MALARIA: INFLUENCE OF ABO GROUPS IN SEVERE MALARIA
PREVALENCE OF RED CELL ALLOANTIBODIES IN PATIENTS OF TERTIARY CARE HOSPITAL IN NORTH INDIA OVER A PERIOD OF 3 YEARS
FREQUENCY OF APPEARANCE OF LOW EXPRESSION RHD AND SUBGROUPS WITHIN THE ABO SYSTEM
ALLOANTIBODIES IN PATIENTS … … EXPERIENCE OF DETECTING AND PROVIDING COMPATIBLE ANTIGEN NEGATIVE RED CELL UNITS IN A TERTIARY CARE CENTRE IN INDIA
MILD HAEMOLYTIC DISEASE OF FETUS AND NEWBORN DUE TO ANTI-GE3
FIRST REPORT OF RH NULL FROM INDIA
IRREGULAR ANTIBODIES SCREENING VALIDATION ON QWALYS 3® EQUIPMENT WITH THE MAGNETIC ERYTHROCYTE TECHNOLOGY
P-409
RESEARCH ON DISTRIBUTION OF BLOOD TYPES IN THE TERRITORY OF TAJIKISTAN
A COMPARATIVE ANALYSIS OF EFFECTS OF DIFFERENT REAGENT RED CELLS IN REVERSE ABO GROUPING
AN AUTOMATED ANTIBODY IDENTIFICATION VALIDATION EXPERIENCE AT EXEMPLA GOOD SAMARITAN MEDICAL CENTER
DISTRIBUTION PATTERN OF IRREGULAR RED CELL ALLOANTIBODIES IN PATIENT WITH THALASSEMIA MAJOR IN NORTHERN IRAN
CASE REPORT: ALLOIMMUNIZATION ANTI-PP1PK IN PREGNANCY
DETERMINATION OF THE CLINICAL SIGNIFICANCE OF M, N AND LEWIS BLOOD GROUP SYSTEM ANTIERYTHROCYTE ANTIBODIES SPECIFICITIES
EVALUATION OF NEW RAPID MNSS TYPING BY FULLY AUTOMATED SYSTEM NEO IMMUCOR®
COMPARATIVE TESTING FOR WEAK AND PARTIAL EXPRESSION OF D ANTIGEN: DIAGAST E.M.® TECHNOLOGY VS ORTHO BIOVUETM SYSTEM AND IMMUCOR GAMMA CAPTURE-R® SELECT TECHNOLOGY
EVALUATION OF IH-1000 ON AUTOMATED ABO-RH TYPING AND IRREGULAR ANTIBODY SCREENING
IMPROVED ABO/RH(D) TYPING IN JAPANESE POPULATION USING GRIFOLS DG GEL® SYSTEM
EVALUATION OF THE NEW IMMUNOHEMATOLOGICAL FULLYAUTOMATED ERYTRA® SYSTEM: PRELIMINARY RESULTS
ANTI-HLA-B7 REACTIVE IN COLUMN AGGLUTINATION AND ELUTED AFTER ABSORBTION FROM RBCS
PERFORMANCE OF THE AUTOMATED IMMUNOHEMATOLOGY ANALYZER WITH GLASS BEADS COLUMN AGGLUTINATION TECHNOLOGY
MOLECULAR AND SEROLOGIC CHARACTERIZATION OF ABO DISCREPANCIES IN KOREAN POPULATION
AN EXAMPLE OF PREFERENTIAL BINDING OF ANTI FY5 TO RH-LITTLE-E POSITIVE CELLS
VALIDATION OF NEO AUTOMATED IMMUNOHEMATOLOGY ANALYZER
EVALUATION OF ERYTRA®, A FULLY AUTOMATED INSTRUMENT WITH A HIGH PROCESSING CAPACITY FOR PRETRANSFUSION COMPATIBILITY TESTS, IN THE VALPARAÍSO BLOOD CENTRE (CHILE)
EVALUATION OF THE AUTOMATED QWALYS 3 SYSTEM FOR ABO/D GROUPING AND UNEXPECTED ANTIBODY SCREENING
P-428
FREQUENCY OF COMMON RH ANTIGENS AND RH PHENOTYPES IN THE INDIAN BLOOD DONOR POPULATION
SCIENTIFIC SUPPORT OF INSTITUTO LICON TO MEXICAN HEALTH INSTITUTIONS, FOR THE CONTINUING EDUCATION IN BLOOD BANKS THROUGH IMMUNOHEMATOLOGICAL CASES RESOLUTION
COMPARISON OF DIRECT ANTIGLOBULIN TESTS USING E.M.® TECHNOLOGY AND ORTHO BIOVUETM SYSTEM
IRREGULAR ANTIBODIES IN DONATED BLOOD, CENTER FOR BLOOD TRANSFUSION, PUEBLA, MÉXICO: JUNE 2009-DECEMBER 2011
A PREGNANT WOMAN WITH ANTIBODIES AGAINST A HIGHFREQUENCY RH ANTIGEN
FACTORS AFFECTING RED CELL ALLOIMMUNIZATION (A RETROSPECTIVE STUDY OF 206 EGYPTIAN MULTITRANSFUSED PATIENTS)
BLOOD GROUP ANTIGEN DISTRIBUTION IN LAO BLOOD DONORS
DONORS WEAK D ANTIGEN DETECTION THANKS TO ERYTHROCYTE MAGNETIZED TECHNOLOGY - QWALYS SYSTEM
IMMEDIATE SPIN CROSSMATCH IN PATIENTS WHO HAD NEGATIVE IRREGULAR ANTIBODY: PRELIMINARY DATA IN THAI PATIENTS
RED CELL ANTIBODY DETECTION AND IDENTIFICATION - 1 YEAR STUDY IN A DELHI BLOOD BANK
A HIGH TITRE COLD AUTO-AGGLUTININ IN A SEPTUAGENARIAN WOMAN COMPLICATING PRE-TRANSFUSION COMPATIBILITY TESTS
A STUDY OF PREVALENCE OF RED CELL AUTOANTIBODIES AND ALLOANTIBODIES IN A POPULATION OF SINGAPORE PATIENTS IN 2010
RH SYSTEM ANTIGEN DISTRIBUTION IN A LARGE POPULATION OF DONORS IN LIMA, PERU
P-442
AUTOMATED TPHA SCREENING ON GALILEO AND NEO SYSTEMS
RED CELL ALLOIMMUNIZATION IN TRANSFUSION-DEPENDENT THALASSAEMIC PATIENTS
TRANSFUSION THERAPY FOR PATIENT's WITH AUTO IMMUNE HEMOLYTIC ANEMIA: LEAST INCOMPATIBLE OR PARTIAL PHENOTYPE MATCHED BLOOD TRANSFUSION
FREQUENCY AND SPECIFICITY OF IRREGULAR RED CELL ANTIBODIES IN CARDIAC SURGERY IN 2351 PATIENTS AT THE NATIONAL INSTITUTE OF CARDIOLOGY ‘IGNACIO CHAVEZ’
EVALUATION OF ERYTRA® IN A BLOOD CENTER WITH SIGNIFICANT ACTIVITY OF COLLECTION, PROCESSING AND STORAGE OF BLOOD COMPONENTS
EVALUATION ON THE REAGENTS AND FULLY AUTOMATED MACHINE ERYTHROCYTE MAGNETIZED TECHNOLOGY (EMT) QWALYS3
IMPORTANCE OF COLD AUTOIMMUNE ANTIBODIES IN REGULARLY TRANSFUSED PATIENT WITH HEMATOLOGY DISORDERS
SYNONYMOUS NUCLEOTIDE POLYMORPHISMS IMPACT DOMBROCK BLOOD GROUP ALLELE EXPRESSION IN K562 TRANSDUCED CELLS
NOVEL KEL HETEROZYGOUS MUTATIONS ASSOCIATED WITH WEAKENING OF KELL ANTIGENS KEL1 AND KEL2
A NEW CASE AND A NOVEL MOLECULAR BACKGROUND IN A MER2-NEGATIVE (RAPH:-1) INDIVIDUAL WITH ANTI-MER2
IDENTIFICATION OF GENOMIC BREAKPOINT IN (C) CES TYPE 1 VARIANT AND DEVELOPMENT OF A NEW MOLECULAR TOOL FOR ITS SPECIFIC DETECTION
A HIGH-THROUGHPUT METHOD FOR ACCURATE DETECTION OF RHD*D-CE(4–7)-D VARIANT
CRAG: A NEW HIGH-PREVALENCE ANTIGEN IN THE CROMER BLOOD GROUP SYSTEM
CROK - A NOVEL MUTATION OF THE CROMER BLOOD GROUP SYSTEM
A NEW GLYCOPHORIN B ALLELE, GYPB (IVS5 + 3G>A), IN TRANS TO GYPB (IVS5 + 5G>T) IS ASSOCIATED WITH DISCREPANT PREDICTION OF S AND U ANTIGEN STATUS
APPLICATION OF THE NOVEL HIGH-THROUGHPUT GENOTYPING MLPA ASSAY IN RHD GENOTYPING FOR A CHINESE PEDIGREE WITH DEL PHENOTYPE
CHARACTERIZATION OF THREE NOVEL ABCG2 NULL ALLELES; THE JR BLOOD GROUP SYSTEM (PROVISIONALLY ISBT 032)
THE HYBRID RHD ALLELE RHD-CE(3–4)-D REPRESENTS DFR-5, A NEW MEMBER IN THE DFR FAMILY OF PARTIAL D
MOLECULAR AND SEROLOGICAL CHARACTERIZATION OF THE RARE P PHENOTYPE IN ISRAEL
INTRONIC POLYMORPHISM I8–32C WITHIN RHD GENE AS A MARKER OF A PECULIAR RHCE HAPLOTYPE: PRELIMINARY STUDY IN 104 CASES
KLF1 MUTATIONS IN JAPANESE INDIVIDUALS WITH IN(LU) PHENOTYPE
A NEW GP(B-A-B) HYBRID MOLECULE (GP.YAK) WITH MILTENBERGER PHENOTYPE
EVALUATION OF A LUMINEX BASED ASSAY FOR BLOOD GROUP GENOTYPING IN A POPULATION OF HIGHLY DIVERSE ANCESTRY
NON-INVASIVE FETAL RHD GENOTYPING BY REAL-TIME PCR: 3 YEARS OF EXPERIENCE IN PORTUGAL
MOLECULAR BASIS OF WEAK D AND DEL IN ANHUI CHINESE HAN POPULATION
RHD VARIANTS AMONG POLISH D NEGATIVE BLOOD DONORS
RED CELL BLOOD GROUP GENOTYPING: A COMPARISON OF THE PROGENIKA BLOODCHIP AND EXISTING METHODS IN A TERTIARY REFERENCE LABORATORY
THE LU7/LU:-7 POLYMORPHISM IS DEFINED BY A MISSENSE NUCLEOTIDE CHANGE: LU*1274A>C
INTRODUCTION OF AN VALIDATED IN-HOUSE HIGH THROUGHPUT BLOOD GROUP GENOTYPING SYSTEM INTO A ROUTINE SETTING
RHD ALLELES ASSOCIATED WITH AUTO ANTI-D IN PATIENTS OF DIVERSE ANCESTRY
WEAKENED EXPRESSION OF K11 ON RBCS LACKING KANT (KEL33), AND KETI (KEL36)
RHD ZYGOSITY BY SEROLOGICAL AND MOLECULAR METHODS IN THE DONOR POPULATION OF MUMBAI, INDIA
SCREENING AND CHARACTERIZATION OF DEL BY SEROLOGIC AND GENETIC METHODS IN A KOREAN POPULATION
MOLECULAR CHARACTERIZATION OF A NEW D—ALLELE IN COMORIAN
P-477
STRATEGY TO IDENTIFY D VARIANTS IN A MULTIETHNIC POPULATION
A NOVEL MUTATION OF RHD ANTIGEN
ASSOCIATION OF ALTERED E RHCE*CE(697G,712G,733G,744C) WITH ALTERED D RHD*46C
MOLECULAR MATCHING OF RED BLOOD CELLS IS SUPERIOR TO THE SEROLOGICAL MATCHING IN SICKLE CELL DISEASE PATIENTS
MOLECULAR GENOTYPING AND FREQUENCES OF BLOOD GROUP ANTIGENS IN KUWAIT CENTRAL BLOOD BANK
A NOVEL RHCE ALLELE: RHCE*CE(254G, 733G)
PATIENTS AND DONORS BLOOD GROUP GENOTYPING FOR AN EFFICIENT BLOOD THERAPY
MOLECULAR BASIS OF WEAK EXPRESSION OF D ANTIGEN IN POLAND
SEROLOGIC REACTIVITY AND MOLECULAR ANALYSIS OF A VARIANT D PHENOTYPE
EVALUATION OF A BLOOD GROUP GENOTYPING PLATFORM IN JAPANESE SAMPLES
A NEW STRATEGY TO IDENTIFY RARE BLOOD DONORS: SINGLE PCR MULTIPLEX SNAPSHOT REACTION FOR DETECTION OF 16 BLOOD GROUP ALLELES
MOLECULAR CHARACTERIZATION OF D VARIANTS IN BRAZILIANS REVEALS A HIGH FREQUENCY OF THE PARTIAL D DFR
IDENTIFICATION OF RHCE VARIANT ALLELES: A COMPARISON OF LABORATORY-DEVELOPED DNA TESTS AND A COMMERCIAL DNA ARRAY METHOD
NEW RHD VARIANT FOUND IN PORTUGUESE BLOOD DONORS
HLA ALLOIMMUNIZATION IS ASSOCIATED WITH RBC ANTIBODIES IN MULTIPLY TRANSFUSED PATIENTS FROM BRAZIL
RHD*DIII.4 ALLELE WITH ADDITIONAL NUCLEOTIDE CHANGE 307 T>C
CERN/CEBP: A RARE RHCE COMPOUND HETEROZYGOTE
ALLELIC PREVALENCE OF ABO BLOOD GROUP GENES USING MULTIPLEX ALLELE - SPECIFIC PCR IN IRANIAN AZARI POPULATION
APPLICATION OF HIGH-THROUGHPUT GENOTYPING MLPA ASSAY TO ASSIST DIAGNOSIS OF A SEVERE CASE OF HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ANTI-DIA
A NOVEL O ALLELE CAUSED BY A IN-FRAME TRIPLET DELETION IN ABO GENE
THE GENE FREQUENCIES OF 8 MINOR BLOOD GROUP SYSTEMS IN BLOOD DONORS OF GROUP O FROM MEISHAN CITY IN CHINA
BIORHEOLOGIC ACTION OF PHYLLANTHUS SELLOWIANUS EXTRACTS ON ERYTROCYTE ADHESION BY IMAGES DIGITAL ANALYSIS
TWO MUTATION FOUND IN (1,4) GALACTOSYLTRANSFERASE GENE IN TWO CHINESE INDIVIDUALS WITH THE P PHENOTYPE
P-501
BLOOD TYPE BY GENOTYPING TECHNIQUE VS HAEMAGGLUTINATION IN TUBE TECHNIQUE IN PATIENTS AND BLOOD DONORS AT NATIONAL MEDICAL CENTRE BLOOD BANK ‘LA RAZA’ IMSS
FACTITIOUS DISORDER BY PROXY: TWO DIFFERENT CASES
RHD*WEAK 4.3 IS ASSOCIATED WITH AN ALTERED RHCE*CE EXPRESSING CX AND VS
MOLECULAR IDENTIFICATION OF CERTAIN ALLELES IN ERYTHROCYTE SYSTEMS (KPA, KBP, LUA, LUB, DIA, DIB, WRA, WRB, YTA, YTB, COA, COB, KNA, KNB, DOA, DOB) IN BLOOD DONORS LIVING IN MEXICO CITY
ASSOCIATION OF BLOOD GROUP ALELES AND ANCESTRY
16TH ISBT INTERNATIONAL PLATELET IMMUNOLOGY WORKSHOP - PRELIMINARY ANALYSES
FAILURE DETECTION OF ANTI-HPA-1A ANTIBODY IN THE SERUM OF A PLATELET REFRACTORINESS PATIENT DUE TO HPA-1A+ PLATELET TRANSFUSION ABSORPTION
PREPARATION AND ACTIVITY ANALYSIS OF MOUSE ANTI HUMAN PLATELET CD36 MONOCLONAL ANTIBODY
FREQUENCY OF ANTI-PLATELET ANTIBODIES IN POLYTRANSFUSED HEMATOLOGIC PATIENTS ON SOLID PHASE TESTS
DETECTION AND DIAGNOSIS OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA PURPURA CAUSED BY ANTI HPA-3A ANTIBODY
PLATELET CROSSMATCH TEST USING SOLID-PHASE MICROPLATE TECHNIQUES
PLATELET GENOTYPING AT THE BLOOD BANK AT THE NATIONAL MEDICAL CENTRE ‘LA RAZA’, MEXICAN INSTITUTE OF SOCIAL SECURITY: FIRST REPORT IN MEXICO
THE ESTABLISHMENT OF CELL ENGINEERING LABORATORY FOR THE STUDY ON BLOOD CELLS POLYMORPHISM
THE RESEARCH OF ALLOIMMUNIZATION IN PLATELETS TRANSFUSION REFRACTORY AT PATIENTS WITH ACUTE LEUKEMIA
THE NEW CD36 DEFICIENCY CASES IN FOUR GUANGZHOU BLOOD DONORS
HUMAN NEUTROPHIL ANTIGEN (HNA)-1, HNA-3, HNA-4 AND HNA-5 ALLELE FREQUENCIES IN A PANEL OF APHERESIS DONORS FROM ENGLAND USING A HIGH THROUGHPUT MULTIPLEX LUMINEX DNA BEAD ASSAY
THE FREQUENCIES OF HUMAN NEUTROPHIL ALLOANTIGENS-1,2,4,5 IN SOUTHERN CHINESE POPULATION
RATES AND CAUSES OF FALSE POSITIVE RESULTS OF NONINVASIVE DETERMINATION OF ANTENATAL RHD STATUS
MICROCHIMERISM IN THE TRANSFUSED OBSTETRIC POPULATION
IMPORTANCE OF SAMPLING TIME FOR THE KLEIHAUER -BETKE METHO
THE INCIDENCE OF ERYTHROCYTE ALLOIMMUNIZATION IN PREGNANT WOMEN
SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN DUE TO ANTI-G
PHARMACOKINETICS AND SAFETY OF ROLEDUMAB, A NOVEL HUMAN RECOMBINANT MONOCLONAL ANTI-RHD ANTIBODY WITH AN OPTIMIZED FC FOR IMPROVED ENGAGEMENT OF FCGRIII, IN HEALTHY VOLUNTEERS
THE DECREASE OF SOLUBLE HLA-G MOLECULES IN FETAL AND MATERNAL BLOOD TRIGGERS PARTURITION MIMICKING FETAL REJECTION
COMPARISON OF ESTIMATION OF FETOMATERNAL HEMORRHAGE USING KLEIHAUER-BETKE TEST AND MICROCOLUMN GEL TECHNIQUE IN RH D- NEGATIVE NON ISOIMMUNISED MOTHERS
COMPARISON OF GEL TEST AND CONVENTIONAL TUBE TEST FOR ANTIBODY DETECTION AND TITRATION IN D-NEGATIVE PREGNANT WOMEN
SPONTANEOUS ANTEPARTAL RHD ALLOIMMUNIZATION
P-531
PROFILE OF MATERNAL RED CELL ALLO-ANTIBODIES IN PREGNANCY: REPORT FROM A DEVELOPING COUNTRY
USE OF MONOCLONAL IGM ANTI-D TO SCREEN FOR FETOMATERNAL HEMORRHAGE
THE EVALUATION OF TRANSCUTANEOUS BILIRUBIN MEASUREMENT FOR DIAGNOSING NEWBORNS WITH ABO HEMOLYTIC DISEASE
TO ASSESS THE FEASIBILITY OF DEDICATED DONOR UNITS FOR TRANSFUSION IN NEONATES AND INFANTS (<3 MONTHS) UNDERGOING SURGERY
P-536
AUTOLOGOUS BLOOD TRANSFUSION IN CHILDREN
DETERMINATION OF THE MEAN RED CELL TRANSFUSION REQUIREMENT COMPARED ON THE BASIS OF IRON OVERLOAD AND TYPE OF CHELATION THERAPY IN PEDIATRIC MULTIPLY TRANSFUSED THALASSEMIA MAJOR PATIENTS
ANALYSIS OF STRATEGIES FOR ABO INCOMPATIBLE KIDNEY AND LIVER TRANSPLANTATION
ROLE OF THERAPEUTIC PLASMA EXCHANGE IN VARIOUS CLINICAL SETTINGS
MONONUCLEAR CELL COLLECTION FOR EXTRACORPOREAL PHOTOCHEMOTHERAPY: A COMPARATIVE STUDY ON THE NEW AUTOMATED SPECTRA OPTIA V 5.0 AND THE COBE SPECTRA MNC APHERESIS DEVICES
BLOOD DONATION INDUCED LOWERED PLASMA LIPIDS - AN INDICATION FOR ITS THERAPEUTIC ADAPTATIONS IN NIGERIANS
CURRENT SITUATION OF THERAPEUTIC APHERESIS IN NATIONAL BLOOD TRANSFUSION CENTRE OF TIRANA
REVIEW OF THERAPEUTIC APHERESIS PROCEDURES IN A TERTIARY CARE HOSPITAL IN INDIA
THERAPEUTIC PLASMA EXCHANGE IN NEUROLOGICAL PATIENTS IN 2011 - OUR EXPERIENCE
RED BLOOD CELL ALLOIMMUNIZATION RISK IS NOT ASSOCIATED WITH STORAGE TIME OF TRANSFUSED CELLS
COLLOID TREATMENT IN SEPSIS PATIENTS IN INTENSIVE CARE - USE OF ALBUMIN VS HYDROXYETHYL STARCH (HES) IS COST-EFFECTIVE IN A DECISION ANALYSIS MODEL
THE EFFECT OF DONOR SEX ON TRANSFUSION RECIPIENT MORTALITY - RESULTS FROM A SECOND HOSPITAL
ASSESSMENT OF BLOOD COMPONENTS NEEDS IN A HIGH COMPLEXITY PEDIATRIC HOSPITAL
INFLUENTIAL FACTORS IN THE EFFICACY OF BLOOD COMPONENT TRANSFUSION IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT
AUDIT OF ROLE OF BLOOD BANK IN RENAL TRANSPLANTATION
THROMBOCYTOPENIA IN PERINATAL PERIOD: A PREDICTOR OF CONSUMPTION COAGULOPATHY
THE USE OF LARGE DOSE OF RH-IMMUNOGLOBULIN FOR THE PREVENTION OF ANTI-D ALLOIMMUNIZATION IN RHD-INCOMPATIBLE LIVER TRANSPLANTATION
BLOOD TRANSFUSION AND ANEMIA IN ELDERLY PATIENTS
IMPLIMENTATION OF MAXIMUM SURGICAL BLOOD ORDERING SHEDULE
TRACKING ECMO INDUCED CHANGES TO HAEMOSTASIS WITH ROTEM® AND MULTIPLATE® ANALYSER IN AN OVINE MODEL
PRELIMINARY RESULTS OF ROUTINE COAGULATION PARAMETERS DURING ECMO IN AN OVINE MODEL
P-558
MASSIVE TRANSFUSION: ACTIVATION OF A NEW PROTOCOL
ACQUIRED HEMOPHILIA A IN A PATIENT WITH PREVIOUSLY HEALTHY: CASE REPORT
ACQUIRED HEMOPHILIA, OUR EXPERIENCE
INTRAOPERATIVE CELL SALVAGE IN MAJOR VASCULAR SURGERIES
A 4-YEAR SURVEY OF TRANSFUSION REACTIONS AT THE SWEDISH UNIVERSITY HOSPITAL IN UPPSALA
INFLUENCE OF PLATELET ADDITIVE SOLUTION ON FREQUENCY OF ADVERSE EVENTS FOCUSED ON THE ABO-MATCH OF THE DONOR WITH THE RECIPIENT
ACUTE RESPIRATORY INSUFICIENCY AND TRANSFUSION. COMPLEX ETIOLOGY SYNDROME
THE DIAGNOSIS AND STUDY OF CLINICAL HEMOLYTIC TRANSFUSION REACTIONS IN CHINA
P-567
DETERMINATATION OF DI(2-ETHYLHEXYL)PHTHALATE (DEHP) RELEASED IN BLOOD FROM DISPOSABLE EXTRACORPOREAL CIRCULATION PVC TUBE BY HPLC
COMPARATIVE EFFECTIVENESS OF PLASMA PREPARED WITH PATHOGEN INACTIVATION (INTERCEPTTM) AND QUARANTINE PLASMA (PFCS) FOR THERAPEUTIC PLASMA EXCHANGE OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
ALLERGIC TRANSFUSION REACTIONS IN FRANCE DUE TO METHYLENE BLUE-TREATED PLASMA: ONE SET OF DATA TWO SETS OF CONCLUSIONS
TRANSFUSION REACTION REPORTS BEFORE AND AFTER INTRODUCTION OF MALE ONLY PLASMA IN STOCKHOLM AREA
ANALYSIS OF NATIONAL SURVEYS RELATED TO ABO-INCOMPATIBLE BLOOD TRANSFUSION IN JAPAN
RECEPTOR NOTIFICATIONS FROM 2007 TO 2011: THE EVOLUTION OF THE PORTUGUESE HAEMOVIGILANCE SYSTEM
A COMPARATIVE STUDY OF THE EFFICIENCY OF PLASMA AND ADDITIVE SOLUTION PRESERVED PLATELET CONCENTRATES
DONOR HEMOVIGILANCE: THE USEFULNESS OF EARLY POST-DONATION INFORMATION NOTIFICATION
HAS TRANSFUSION PRACTICE IMPROVED IN AUSTRALIAN HOSPITALS?
COMPARATIVE EFFECTIVENESS OF PLASMA PREPARED WITH PATHOGEN INACTIVATION (INTERCEPTTM) AND QUARANTINE FOR SUPPORT OF LIVER TRANSPLANTATION
HEMOVIGILANCE: AN ANALYSIS OF ADVERSE TRANSFUSION REACTIONS NOTIFIED IN THE STATE OF SÃO PAULO - BRAZIL
P-579
USE OF RED BLOOD CELL CONCENTRATES IN SURGERY: EVIDENCES OF INADEQUATE INDICATIONS
HAEMOVIGILANCE PROGRAM IN THE BLOOD BANK OF NATIONAL INSTITUTE OF PEDIATRICS, MEXICO. IMPROVING THE DATA SINCE THE IMPLEMENTATION
P-582
ADVERSE TRANSFUSION REACTIONS-A 5-YEAR DATA OF SPS APOLLO HOSPITALS, LUDHIANA, PUNJAB, INDIA
HAEMOVIGILANCE: ADVERSE REACTIONS TO TRANSFUSION (2004–2011) BLOOD BANK NATIONAL INSTITUTE CARDIOLOGY ‘IGNACIO CHAVEZ’
A NEW APPROACH FOR TRANSFUSING PATIENTS IN SWITZERLAND
THE FOLLOW OF PEDIATRICS TRANSFUSED PATIENTS AT THE BRAZZAVILLE UNIVERSITY HOSPITAL: NECESSITY OF HAEMOVIGILANCE
P-587
P-588
BEGINNING OF HAEMOVIGILANCE SYSTEM IN SERBIA
INCIDENCE OF POSITIVE CULTURES IN THE BLOOD BANK's BACTERIOLOGICAL CONTROL
EIGHT-YEAR EXPERIENCE OF BLOODLESS SURGERY AT A TERTIARY CARE HOSPITAL IN KOREA
THE PREVALENCE OF PRE-OPERATIVE ANAEMIA IN PATIENTS UNDERGOING ELECTIVE SURGERY
SUCCESSFUL SECONDARY PROPHYLAXIS IN HAEMOPHILIA WITH INHIBITORS USING RFVIIA THREE TIMES PER WEEK
ELEVATED LEVELS OF PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA
RECOMBINANT ACTIVATED FACTOR VIIA IN FULMINANT HEPATIC FAILURE WITH UNOS STATUS 1A PATIENTS: A SINGLE TERTIARY ACADEMIC CENTER EXPERIENCE
P-596
GAMMA-IRRADIATED MESENCHYMAL STROMAL CELLS EXHIBIT IMMUNOSUPPRESSIVE POTENTIAL IN VITRO
EVALUATION OF HUMAN CORD BLOOD CD34+ HEMATOPOIETIC STEM CELL DIFFERENTIATION TO MEGAKARYOCYTE ON PES NANOFIBER SCAFFOLD COMPARE TO 2-D CULTURE SYSTEM
HUMAN UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL CAN BE ENHANCE THE RATE OF OSTEOBLASTIC DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELL IN VITRO
MESENCHYMAL STEM CELL SEPARATION FROM WHARTON's JELLY AND ITS TRANSDIFFERENTIATION INTO KERATINOCYTES
OXIDATIVE PRECONDITIONING OF MESENCHYMAL STEM CELLS ENHANCES THEIR RESISTANCE AGAINST OXIDATIVE STRESS
ISOLATION AND CHARACTERIZATION OF HUMAN UMBILICAL CORD BLOOD MESENCHYMAL STEM CELLS
HARVESTING OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN HEMATOLOGICAL PATIENTS
ADENOVIRUS-MEDIATED EXPRESSION OF THE NUCLEAR FACTOR ERYTHROID-2 RELATED FACTOR 2 PROTEIN WITHIN THE MSCS DECREASED THE CYTOTOXICITY AND INHIBITED THE APOPTOSIS INDUCED BY OXIDATIVE STRESSES
THE POTENTIAL IMPACT OF CELL SEPARATION METHODS ON THE FUNCTIONAL CAPABILITIES OF UCB DERIVED CD133+ CELLS
STANDARDIZATION AND COMPARISON OF IMMUNOSUPPRESSIVE POTENCY TESTS FOR MESENCHYMAL STROMAL CELL - BASED THERAPIES
REGENERATIVE MEDICINE: SYNERGIES IN CELLULAR THERAPY, BLOOD AND TISSUE BANKING
UMBILICAL CORD BLOOD PROCESSING VOLUMES COMPARED TO TOTAL NUCLEATED CELL COUNT AND CD34+ RESULTS
EFFECT OF TIMING OF UMBILICAL CORD CLAMPING ON CORD BLOOD VOLUME COLLECTED
HEMATOPOIETIC MYELOID PROGENITORS CONTENT IN PERIPHERAL BLOOD APHERESIS UNITS OBTAINED OF HEALTHY DONORS AND HEMATOLOGICAL PATIENTS
FLUCTUANT ALDH LEVELS IN HSCS ISOLATED FROM CORD BLOOD IN EXPANSION AND FREEZING
COLLECTION OF PERIPHERAL BLOOD STEM CELLS IN HEALTHY DONORS
EVALUATION OF THE EFFECTIVENESS OF PREPARATION AND THE VIABILITY OF STEM CELLS OBTAINED FROM UMBILICAL CORD BLOOD USING A FLOW CYTOMETER FC 500
EVALUATION OF STEM CELLS QUANTITY OBTAINED IN THE PORTION OF UMBILICAL CORD BLOOD USED FOR BLOOD BANKING IN TERMS OF THEIR SUITABILITY FOR TRANSPLANTATION
IL-15 IS ABLE TO INCREASE THE EX-VIVO EXPANSION OF CYTOKINE INDUCED KILLER CELLS
P-616
P-617
THE USE OF CONTROLLED-RATE VS UNCONTROLLED-RATE FREEZING IN LYMPHOCYTE AND PLATELET CRYOPRESERVATION SETTING
INTRA-PROCEDURE MOBILIZATION OF CD34+ CELLS IN THE COURSE OF APHERESIS PROCEDURES
PLASMA EXCHANGE FOR PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA-HEMOLYTIC UREMIC SYNDROME (TTP-HUS) IN PUSAN NATIONAL UNIVERSITY HOSPITAL (2003–2011)
IMPACT OF THE MOBILIZATION REGIMEN AND THE HARVESTING TECHNIQUE ON THE GRANULOCYTE YIELD IN HEALTHY DONORS FOR GRANULOCYTE TRANSFUSION THERAPY
COMPARISON OF THE SPECTRA OPTIA® APHERESIS SYSTEM AND THE COBE SPECTRA FOR THE COLLECTION OF POLYMORPHONUCLEAR LEUKOCYTES
EVALUATION OF THE SPECTRA OPTIA® APHERESIS SYSTEM MONONUCLEAR CELL (MNC) COLLECTION PROCEDURE IN MULTIPLE MYELOMA PATIENTS
EXPERIENCE IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN IN THE NATIONAL INSTITUTE OF PEDIATRICS. MEXICO CITY
STEM CELL APHERESIS COLLECTION WITH A NOVEL APHERESIS SYSTEM FEATURING ELECTRONIC INTERPHASE MONITORING
P-626
AUTOLOGOUS CD133+ CELLS AS SALVAGE THERAPY FOR CRITICAL LIMB ISCHEMIA
AUTOLOGOUS PLASMA RICH IN PLATELET-DERIVED GROWTH FACTORS FOR TREATMENT OF REFRACTORY OCULAR GRAFT VERSUS HOST DISEASE
P-629
P-630
A NOVEL PATHWAY OF PANCREATIC CANCER COUNTERATTACK MEDIATED BY MUC4
TREATMENT OF AVASCULAR NECROSIS OF THE FEMORAL HEAD BY VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND BONE MORPHOGENETIC PROTEIN-2-TRANSGENIC BONE MARROW MESENCHYMAL STEM CELL
ALEMTUZUMAB (ANTI-CD52) CAN MIMIC HLA ALLOANTIBODIES IN COMPLEMENT-DEPENDENT CYTOTOXICITY ASSAYS FOR SEVERAL MONTHS AFTER WITHDRAWAL OF THE DRUG
EXPRESSION OF HUMAN FACTOR IX IN AMNIOTIC MEMBRANE MESENCHYMAL STEM CELLS
AUTOLOGOUS BONE MARROW-DERIVED AND CULTURED MESENCHYMAL STEM CELL THERAPY FOR AVASCULAR NECROSIS OF THE FEMORAL HEAD
CLINICAL APPLICATION OF UCB IN CHINA
EFFICIENCY OF MEDICAL PLASMAPHERESIS IN BRONCHIAL ASTHMA THERAPY
CONTRIBUTION OF BONE MARROW MESENCHYMAL STEM CELLS TO HEPATIC INJURY IN A RAT MODEL
THE EFFECT OF INTRODUCTION OF TYPE AND SCREEN BLOOD REQUISITION METHOD IN OUR INSTITUTION
P-640
DISTRIBUTION OF MICA ALLELES AND HAPLOTYPES ASSOCIATED WITH HLA-A/B/DRB1 IN CHINA
HLA-DRB1 ALLELES ASSOCIATED WITH THERAPEUTIC RESPONSE IN HEPATITIS C VIRUS INFECTION
A STUDY ON THE CORRELATION OF KILLER IMMUNOGLOBULIN-LIKE RECEPTOR GENE DIVERSITY WITH NASOPHARYNGEAL CARCINOMA IN THE SOUTHERN CHINESE HAN POPULATION
COMPARISON METHODOLOGIES FOR ANTI-HLA ANTIBODY SCREENING AMONG BLOOD DONORS
P-645
FAMILY DONOR SEARCH - SINGLE CENTER EXPERIENCE
FREQUENCY OF HLA-B ALLELES IN AN IRANIAN POPULATION
COMPARISON BETWEEN THE HLA FREQUENCIES OF VOLUNTEER DONORS RECRUITED IN THE CAMPANIA BONE MARROW DONOR REGISTRY AND THE ITALIAN POPULATION (IBMDR)
ROLE OF THE KIR GENES IN THE DEVELOPMENT OF GRAFT-VERSUS-HOST-DISEASE IN PATIENTS WITH HAEMATOPOIETIC STEAM CELL TRANSPLANT
DISADVANTAGES IN THE TIPIFICATION OF HLA OF UMBILICAL CORD BLOOD IN THE BANK CMN ‘LA RAZA’
SUCCESS IN THE RENAL GRAFT SURVIVAL AND ITS ASSOCIATION WITH THE HISTOCOMPATIBILITY TESTING (HLA, PRA% AND CROSSMATCH -CDC-) MADE IN CENTRAL BLOOD BANK FROM NATIONAL MEDICAL CENTRE SXXI, IMSS
ASSOCIATION BETWEEN HLA-A26 AND CMV INFECTION IN HEART TRANSPLANTATION RECIPIENTS
COMPARING TWO DIFFERENTS KITS: LABSCREEN MIXED (ONE LAMBDA) AND LIFESCREEN LIFECODES DELUXE (GENEPROBE) CLASS I AND CLASS II ANTIBODIES
P-654
KIDNEY TRANSPLANTATION AND IMMUNOHEMATOLOGICAL PROFILE IN NAPLES: A COORDINATING REGIONAL EXPERIENCE FROM 2000 TO 2006
A STEP FURTHER IN INNOVATION WITH THE TACSI WHOLE BLOOD PLATFORM: INTERNAL VALIDATION OF EXPECTED FEATURES AND BENEFITS OF A FULL AUTOMATED BLOOD COMPONENT PROCESSING MACHINE
THE EFFECT OF PHARMACOLOGICAL MOBILIZATION OF MESENCHYMAL STEM CELLS IN TREATMENT OF SKIN BURN INJURIES IN AN ANIMAL MODEL
NEW APPROACH FOR THE EVALUATION OF PRION DECONTAMINATION PROCEDURES: IN VITRO AMPLIFICATION OF PRION ON STEEL WIRES
LEUKOCYTE ADHESION DEFICIENCY TYPE III DUE TO A NOVEL MUTATION IN THE FERMT3 GENE
VIABILITY OF PLATELETS STORED IN BAGS OF PVC MADE WITH DIFFERENT CONTENTS OF PLASTICIZER (TOTM)
DECREASED DEFORMABILITY OF ERYTHROCYTE IN BLOOD DONORS WITH THALASSEMIA MINOR
IMPLEMENTATION OF A PRE-ANALYTICAL SYSTEM FOR FULLY AUTOMATED HANDLING OF DONOR SAMPLES